reference_id,authors,title,journal,year,volume,citation_footer,citation_type,citation,urls,pubmed_id,doi,header,reference_type,study_id,PUBMED_ID_TITLE_AUTHORS,PUBMED_ID_TITLE,PUBMED_ID_S2,N_CITATIONS,S2_PDF_LINK,CORE_PDF_LINK,PUBMED_ID
CD013080-bib-0001,"Anude CJ, Eze E, Onyegbutulem HC, Charurat M, Etiebet MA, Ajayi S, et al. ",Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria, BMC Infectious Diseases ,2013,13,    ,['citation-journal']," Anude CJ, Eze E, Onyegbutulem HC, Charurat M, Etiebet MA, Ajayi S, et al. Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria.  BMC Infectious Diseases 2013;13:113. CENTRAL [DOI: 10.1186/1471-2334-13-113]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2334-13-113', 'https://www.ncbi.nlm.nih.gov/pubmed/23452915', 'https://scholar.google.com/scholar_lookup?title=Immuno-virologic+outcomes+and+immuno-virologic+discordance+among+adults+alive+and+on+anti-retroviral+therapy+at+12+months+in+Nigeria+&author=CJ+Anude&author=E+Eze&author=HC+Onyegbutulem&author=M+Charurat&author=MA+Etiebet&author=S+Ajayi&publication_year=2013&hl=en']",23452915,https://doi.org/10.1186/1471-2334-13-113, Anude 2013 {published data only}  ,included,CD013080-bbs2-0001,,23452915,23452915,87.0,https://bmcinfectdis.biomedcentral.com/counter/pdf/10.1186/1471-2334-13-113,,23452915
CD013080-bib-0002,"Apisarnthanarak A, Mundy LM. ",Long-term outcomes of HIV-infected patients with <95% rates of adherence to nonnucleoside reverse-transcriptase inhibitors, Clinical Infectious Diseases ,2010,51,    ,['citation-journal']," Apisarnthanarak A, Mundy LM. Long-term outcomes of HIV-infected patients with <95% rates of adherence to nonnucleoside reverse-transcriptase inhibitors.  Clinical Infectious Diseases 2010;51(1):115-7. CENTRAL [DOI: 10.1086/653445]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1086/653445', 'https://www.ncbi.nlm.nih.gov/pubmed/20518676', 'https://scholar.google.com/scholar_lookup?title=Long-term+outcomes+of+HIV-infected+patients+with+<95%+rates+of+adherence+to+nonnucleoside+reverse-transcriptase+inhibitors+&author=A+Apisarnthanarak&author=LM+Mundy&publication_year=2010&hl=en']",20518676,https://doi.org/10.1086/653445, Apisarnthanarak 2010 {published data only}  ,included,CD013080-bbs2-0002,20518676,20518676,20518676,19.0,https://academic.oup.com/cid/article-pdf/51/1/115/843691/51-1-115a.pdf,,20518676
CD013080-bib-0003,"Avong YK, Van Wyk B, Njab J, Abimiku AG, Ndembi N, Okuma J, et al. ",Adherence to anti-retroviral therapy in North Central Nigeria, Current HIV Research ,2015,13,    ,['citation-journal']," Avong YK, Van Wyk B, Njab J, Abimiku AG, Ndembi N, Okuma J, et al. Adherence to anti-retroviral therapy in North Central Nigeria.  Current HIV Research 2015;13(4):268-78. CENTRAL [DOI: 10.2174/1570162x13666150202094120]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.2174/1570162X13666150202094120', 'https://www.ncbi.nlm.nih.gov/pubmed/25642849', 'https://scholar.google.com/scholar_lookup?title=Adherence+to+anti-retroviral+therapy+in+North+Central+Nigeria&author=YK+Avong&author=B+VanWyk&author=J+Njab&author=AG+Abimiku&author=N+Ndembi&author=J+Okuma&publication_year=2015&hl=en']",25642849,https://doi.org/10.2174/1570162X13666150202094120, Avong 2015 {published data only}  ,included,CD013080-bbs2-0003,,,25642849,10.0,,,25642849
CD013080-bib-0004,"Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. ",Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda, Journal of the International Association of Physicians in AIDS Care ,2009,8,    ,['citation-journal']," Bajunirwe F, Arts EJ, Tisch DJ, King CH, Debanne SM, Sethi AK. Adherence and treatment response among HIV-1-infected adults receiving antiretroviral therapy in a rural government hospital in Southwestern Uganda.  Journal of the International Association of Physicians in AIDS Care 2009;8(2):139-47. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1177/1545109709332470', 'https://www.ncbi.nlm.nih.gov/pubmed/19258526', 'https://scholar.google.com/scholar_lookup?title=Adherence+and+treatment+response+among+HIV-1-infected+adults+receiving+antiretroviral+therapy+in+a+rural+government+hospital+in+Southwestern+Uganda+&author=F+Bajunirwe&author=EJ+Arts&author=DJ+Tisch&author=CH+King&author=SM+Debanne&author=AK+Sethi&publication_year=2009&hl=en']",19258526,https://doi.org/10.1177/1545109709332470, Bajunirwe 2009 {published data only}  ,included,CD013080-bbs2-0004,,,19258526,64.0,https://journals.sagepub.com/doi/pdf/10.1177/1545109709332470,,19258526
CD013080-bib-0005,"Bonjoch A, Paredes R, Domingo P, Cervantes M, Pedrol E, Ribera E, et al. ",Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients, AIDS Research and Human Retroviruses ,2006,22,    ,['citation-journal']," Bonjoch A, Paredes R, Domingo P, Cervantes M, Pedrol E, Ribera E, et al. Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.  AIDS Research and Human Retroviruses 2006;22(4):321-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1089/aid.2006.22.321', 'https://www.ncbi.nlm.nih.gov/pubmed/16623634', 'https://scholar.google.com/scholar_lookup?title=Long-term+safety+and+efficacy+of+nevirapine-based+approaches+in+HIV+type+1-infected+patients+&author=A+Bonjoch&author=R+Paredes&author=P+Domingo&author=M+Cervantes&author=E+Pedrol&author=E+Ribera&publication_year=2006&hl=en']",16623634,https://doi.org/10.1089/aid.2006.22.321, Bonjoch 2006 {published data only}  ,included,CD013080-bbs2-0005,,16623634,16623634,44.0,,,16623634
CD013080-bib-0006,"Cerutti B, Broers B, Masetsibi M, Faturiyele O, Toti-Mokoteli L, Motlatsi M, et al. ","Alcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study", BMC Public Health ,2016,16,    ,['citation-journal']," Cerutti B, Broers B, Masetsibi M, Faturiyele O, Toti-Mokoteli L, Motlatsi M, et al. Alcohol use and depression: link with adherence and viral suppression in adult patients on antiretroviral therapy in rural Lesotho, Southern Africa: a cross-sectional study.  BMC Public Health 2016;16:947. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/s12889-016-3209-4', 'https://www.ncbi.nlm.nih.gov/pubmed/27608764', 'https://scholar.google.com/scholar_lookup?title=Alcohol+use+and+depression:+link+with+adherence+and+viral+suppression+in+adult+patients+on+antiretroviral+therapy+in+rural+Lesotho,+Southern+Africa:+a+cross-sectional+study+&author=B+Cerutti&author=B+Broers&author=M+Masetsibi&author=O+Faturiyele&author=L+Toti-Mokoteli&author=M+Motlatsi&publication_year=2016&hl=en']",27608764,https://doi.org/10.1186/s12889-016-3209-4, Cerutti 2016 {published data only}  ,included,CD013080-bbs2-0006,,27608764,27608764,23.0,https://bmcpublichealth.biomedcentral.com/track/pdf/10.1186/s12889-016-3209-4,,27608764
CD013080-bib-0007,"Cohen CJ, Molina JM, Cahn P, Clotet B, Fourie J, Grinsztejn B, et al. ",Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE trials, Journal of Acquired Immune Deficiency Syndromes ,2012,60,    ,['citation-journal']," Cohen CJ, Molina JM, Cahn P, Clotet B, Fourie J, Grinsztejn B, et al. Efficacy and safety of rilpivirine (TMC278) versus efavirenz at 48 weeks in treatment-naive HIV-1-infected patients: pooled results from the phase 3 double-blind randomized ECHO and THRIVE trials.  Journal of Acquired Immune Deficiency Syndromes 2012;60(1):33-42. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAI.0b013e31824d006e', 'https://www.ncbi.nlm.nih.gov/pubmed/22343174', 'https://scholar.google.com/scholar_lookup?title=Efficacy+and+safety+of+rilpivirine+(TMC278)+versus+efavirenz+at+48+weeks+in+treatment-naive+HIV-1-infected+patients:+pooled+results+from+the+phase+3+double-blind+randomized+ECHO+and+THRIVE+trials+&author=CJ+Cohen&author=JM+Molina&author=P+Cahn&author=B+Clotet&author=J+Fourie&author=B+Grinsztejn&publication_year=2012&hl=en']",22343174,https://doi.org/10.1097/QAI.0b013e31824d006e, Cohen 2012 {published data only}  ,included,CD013080-bbs2-0007,,,22343174,156.0,https://doi.org/10.1097/qai.0b013e31824d006e,,22343174
CD013080-bib-0008,"Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Musa BM, et al. ",Socio-demographic and adherence factors associated with viral load suppression in HIV-infected adults initiating therapy in Northern Nigeria: a randomized controlled trial of a peer support intervention, Current HIV Research ,2015,13,    ,['citation-journal']," Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Musa BM, et al. Socio-demographic and adherence factors associated with viral load suppression in HIV-infected adults initiating therapy in Northern Nigeria: a randomized controlled trial of a peer support intervention.  Current HIV Research 2015;13(4):279-85. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.2174/1570162X13666150407143838', 'https://www.ncbi.nlm.nih.gov/pubmed/25845393', 'https://scholar.google.com/scholar_lookup?title=Socio-demographic+and+adherence+factors+associated+with+viral+load+suppression+in+HIV-infected+adults+initiating+therapy+in+Northern+Nigeria:+a+randomized+controlled+trial+of+a+peer+support+intervention+&author=M+Coker&author=MA+Etiebet&author=H+Chang&author=G+Awwal&author=J+Jumare&author=BM+Musa&publication_year=2015&hl=en']",25845393,https://doi.org/10.2174/1570162X13666150407143838, Coker 2015 {published data only}  ,included,CD013080-bbs2-0008,,,25845393,28.0,,,25845393
CD013080-bib-0009,"Davies MA, Boulle A, Fakir T, Nuttall J, Eley B. ","Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study", BMC Pediatrics ,2008,8,    ,['citation-journal']," Davies MA, Boulle A, Fakir T, Nuttall J, Eley B. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study.  BMC Pediatrics 2008;8:34. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2431-8-34', 'https://www.ncbi.nlm.nih.gov/pubmed/18771599', 'https://scholar.google.com/scholar_lookup?title=Adherence+to+antiretroviral+therapy+in+young+children+in+Cape+Town,+South+Africa,+measured+by+medication+return+and+caregiver+self-report:+a+prospective+cohort+study+&author=MA+Davies&author=A+Boulle&author=T+Fakir&author=J+Nuttall&author=B+Eley&publication_year=2008&hl=en']",18771599,https://doi.org/10.1186/1471-2431-8-34, Davies 2008 {published data only}  ,included,CD013080-bbs2-0009,,,18771599,119.0,https://bmcpediatr.biomedcentral.com/counter/pdf/10.1186/1471-2431-8-34,,18771599
CD013080-bib-0010,"Duarte HA, Harris DR, Tassiopoulos K, Leister E, Negrini SF, Ferreira FF, et al. ",Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America, Brazilian Journal of Infectious Diseases ,2015,19,    ,['citation-journal']," Duarte HA, Harris DR, Tassiopoulos K, Leister E, Negrini SF, Ferreira FF, et al. Relationship between viral load and behavioral measures of adherence to antiretroviral therapy in children living with human immunodeficiency virus in Latin America.  Brazilian Journal of Infectious Diseases 2015;19(3):263-71. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1016/j.bjid.2015.01.004', 'https://scholar.google.com/scholar_lookup?title=Relationship+between+viral+load+and+behavioral+measures+of+adherence+to+antiretroviral+therapy+in+children+living+with+human+immunodeficiency+virus+in+Latin+America+&author=HA+Duarte&author=DR+Harris&author=K+Tassiopoulos&author=E+Leister&author=SF+Negrini&author=FF+Ferreira&publication_year=2015&hl=en']",,https://doi.org/10.1016/j.bjid.2015.01.004, Duarte 2015 {published data only}  ,included,CD013080-bbs2-0010,,,25743569,17.0,https://doi.org/10.1016/j.bjid.2015.01.004,,25743569
CD013080-bib-0011,"Dziva Chikwari C, Ferrand RA, Simms V. ",Association between self-reported adherence and HIV viral load suppression among older children and adolescents, Journal of Acquired Immune Deficiency Syndromes ,2017,76,    ,['citation-journal']," Dziva Chikwari C, Ferrand RA, Simms V. Association between self-reported adherence and HIV viral load suppression among older children and adolescents.  Journal of Acquired Immune Deficiency Syndromes 2017;76(3):e87-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAI.0000000000001501', 'https://www.ncbi.nlm.nih.gov/pubmed/28708812', 'https://scholar.google.com/scholar_lookup?title=Association+between+self-reported+adherence+and+HIV+viral+load+suppression+among+older+children+and+adolescents+&author=C+DzivaChikwari&author=RA+Ferrand&author=V+Simms&publication_year=2017&hl=en']",28708812,https://doi.org/10.1097/QAI.0000000000001501, Dziva 2017 {published data only}  ,included,CD013080-bbs2-0011,28708812,,28708812,17.0,https://europepmc.org/articles/pmc5638017?pdf=render,,28708812
CD013080-bib-0012,"Ekstrand ML, Chandy S, Heylen E, Steward W, Singh G. ",Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study, Journal of Acquired Immune Deficiency Syndromes ,2010,53,    ,['citation-journal']," Ekstrand ML, Chandy S, Heylen E, Steward W, Singh G. Developing useful highly active antiretroviral therapy adherence measures for India: the Prerana study.  Journal of Acquired Immune Deficiency Syndromes 2010;53(3):415-6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAI.0b013e3181ba3e4e', 'https://www.ncbi.nlm.nih.gov/pubmed/20190588', 'https://scholar.google.com/scholar_lookup?title=Developing+useful+highly+active+antiretroviral+therapy+adherence+measures+for+India:+the+Prerana+study+&author=ML+Ekstrand&author=S+Chandy&author=E+Heylen&author=W+Steward&author=G+Singh&publication_year=2010&hl=en']",20190588,https://doi.org/10.1097/QAI.0b013e3181ba3e4e, Ekstrand 2010 {published data only}  ,included,CD013080-bbs2-0012,20190588,20190588,20190588,46.0,https://doi.org/10.1097/qai.0b013e3181ba3e4e,,20190588
CD013080-bib-0013,"El-Khatib Z, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Karstaedt A, et al. ","Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa", AIDS ,2010,24,    ,['citation-journal']," El-Khatib Z, Ekstrom AM, Ledwaba J, Mohapi L, Laher F, Karstaedt A, et al. Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South Africa.  AIDS 2010;24(11):1679-87. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAD.0b013e32833a097b', 'https://www.ncbi.nlm.nih.gov/pubmed/20453629', 'https://scholar.google.com/scholar_lookup?title=Viremia+and+drug+resistance+among+HIV-1+patients+on+antiretroviral+treatment:+a+cross-sectional+study+in+Soweto,+South+Africa+&author=Z+El-Khatib&author=AM+Ekstrom&author=J+Ledwaba&author=L+Mohapi&author=F+Laher&author=A+Karstaedt&publication_year=2010&hl=en']",20453629,https://doi.org/10.1097/QAD.0b013e32833a097b, El‐Khatib 2010 {published data only}  ,included,CD013080-bbs2-0013,,20453629,20453629,125.0,https://doi.org/10.1097/qad.0b013e32833a097b,,20453629
CD013080-bib-0014,"Evans D, Berhanu R, Moyo F, Nguweneza A, Long L, Fox MP. ","Can short-term use of electronic patient adherence monitoring devices improve adherence in patients failing second-line antiretroviral therapy? Evidence from a pilot study in Johannesburg, South Africa", AIDS and Behavior ,2016,20,    ,['citation-journal']," Evans D, Berhanu R, Moyo F, Nguweneza A, Long L, Fox MP. Can short-term use of electronic patient adherence monitoring devices improve adherence in patients failing second-line antiretroviral therapy? Evidence from a pilot study in Johannesburg, South Africa.  AIDS and Behavior 2016;20(11):2717-28. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s10461-016-1417-7', 'https://www.ncbi.nlm.nih.gov/pubmed/27146828', 'https://scholar.google.com/scholar_lookup?title=Can+short-term+use+of+electronic+patient+adherence+monitoring+devices+improve+adherence+in+patients+failing+second-line+antiretroviral+therapy?+Evidence+from+a+pilot+study+in+Johannesburg,+South+Africa+&author=D+Evans&author=R+Berhanu&author=F+Moyo&author=A+Nguweneza&author=L+Long&author=MP+Fox&publication_year=2016&hl=en']",27146828,https://doi.org/10.1007/s10461-016-1417-7, Evans 2016 {published data only}  ,included,CD013080-bbs2-0014,27146828,27146828,27146828,17.0,https://link.springer.com/content/pdf/10.1007%2Fs10461-016-1417-7.pdf,,27146828
CD013080-bib-0015,"Farley J, Hines S, Musk A, Ferrus S, Tepper V. ","Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping", Journal of Acquired Immune Deficiency Syndromes ,2003,33,    ,['citation-journal']," Farley J, Hines S, Musk A, Ferrus S, Tepper V. Assessment of adherence to antiviral therapy in HIV-infected children using the Medication Event Monitoring System, pharmacy refill, provider assessment, caregiver self-report, and appointment keeping.  Journal of Acquired Immune Deficiency Syndromes 2003;33(2):211-8. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/00126334-200306010-00016', 'https://www.ncbi.nlm.nih.gov/pubmed/12794557', 'https://scholar.google.com/scholar_lookup?title=Assessment+of+adherence+to+antiviral+therapy+in+HIV-infected+children+using+the+Medication+Event+Monitoring+System,+pharmacy+refill,+provider+assessment,+caregiver+self-report,+and+appointment+keeping+&author=J+Farley&author=S+Hines&author=A+Musk&author=S+Ferrus&author=V+Tepper&publication_year=2003&hl=en']",12794557,https://doi.org/10.1097/00126334-200306010-00016, Farley 2003 {published data only}  ,included,CD013080-bbs2-0015,12794557,12794557,12794557,171.0,https://doi.org/10.1097/00126334-200306010-00016,,12794557
CD013080-bib-0016,"Fokam J, Billong SC, Jogue F, Moyo Tetang Ndiang S, Nga Motaze AC, Paul KN, et al. ",Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaounde-Cameroon, PLOS One ,2017,12,    ,['citation-journal']," Fokam J, Billong SC, Jogue F, Moyo Tetang Ndiang S, Nga Motaze AC, Paul KN, et al. Immuno-virological response and associated factors amongst HIV-1 vertically infected adolescents in Yaounde-Cameroon.  PLOS One 2017;12(11):e0187566. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0187566', 'https://www.ncbi.nlm.nih.gov/pubmed/29112991', 'https://scholar.google.com/scholar_lookup?title=Immuno-virological+response+and+associated+factors+amongst+HIV-1+vertically+infected+adolescents+in+Yaounde-Cameroon+&author=J+Fokam&author=SC+Billong&author=F+Jogue&author=S+MoyoTetangNdiang&author=AC+NgaMotaze&author=KN+Paul&publication_year=2017&hl=en']",29112991,https://doi.org/10.1371/journal.pone.0187566, Fokam 2017 {published data only}  ,included,CD013080-bbs2-0016,,29112991,29112991,39.0,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0187566&type=printable,,29112991
CD013080-bib-0017,"Gill CJ, Sabin LL, Hamer DH, Keyi X, Jianbo Z, Li T, et al. ",Importance of dose timing to achieving undetectable viral loads, AIDS and Behavior ,2010,14,    ,['citation-journal']," Gill CJ, Sabin LL, Hamer DH, Keyi X, Jianbo Z, Li T, et al. Importance of dose timing to achieving undetectable viral loads.  AIDS and Behavior 2010;14(4):785-93. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s10461-009-9555-9', 'https://www.ncbi.nlm.nih.gov/pubmed/19353263', 'https://scholar.google.com/scholar_lookup?title=Importance+of+dose+timing+to+achieving+undetectable+viral+loads&author=CJ+Gill&author=LL+Sabin&author=DH+Hamer&author=X+Keyi&author=Z+Jianbo&author=T+Li&publication_year=2010&hl=en']",19353263,https://doi.org/10.1007/s10461-009-9555-9, Gill 2010 {published data only}  ,included,CD013080-bbs2-0017,,19353263,19353263,42.0,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857692,,19353263
CD013080-bib-0018,"Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, Mulenga V, et al. ","Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects", PLOS One ,2011,6,    ,['citation-journal']," Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, Mulenga V, et al. Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.  PLOS One 2011;6(4):e18505. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0018505', 'https://www.ncbi.nlm.nih.gov/pubmed/21533031', 'https://scholar.google.com/scholar_lookup?title=Excellent+adherence+to+antiretrovirals+in+HIV++Zambian+children+is+compromised+by+disrupted+routine,+HIV+nondisclosure,+and+paradoxical+income+effects+&author=JE+Haberer&author=A+Cook&author=AS+Walker&author=M+Ngambi&author=A+Ferrier&author=V+Mulenga&publication_year=2011&hl=en']",21533031,https://doi.org/10.1371/journal.pone.0018505, Haberer 2011 {published data only}  ,included,CD013080-bbs2-0018,,21533031,21533031,131.0,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0018505&type=printable,,21533031
CD013080-bib-0019,"Hassan AS, Nabwera HM, Mwaringa SM, Obonyo CA, Sanders EJ, De Wit TFR, et al. ",HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study, AIDS Research and Therapy ,2014,11,    ,['citation-journal']," Hassan AS, Nabwera HM, Mwaringa SM, Obonyo CA, Sanders EJ, De Wit TFR, et al. HIV-1 virologic failure and acquired drug resistance among first-line antiretroviral experienced adults at a rural HIV clinic in coastal Kenya: a cross-sectional study.  AIDS Research and Therapy 2014;11(1):9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1742-6405-11-9', 'https://www.ncbi.nlm.nih.gov/pubmed/24456757', 'https://scholar.google.com/scholar_lookup?title=HIV-1+virologic+failure+and+acquired+drug+resistance+among+first-line+antiretroviral+experienced+adults+at+a+rural+HIV+clinic+in+coastal+Kenya:+a+cross-sectional+study+&author=AS+Hassan&author=HM+Nabwera&author=SM+Mwaringa&author=CA+Obonyo&author=EJ+Sanders&author=TFR+DeWit&publication_year=2014&hl=en']",24456757,https://doi.org/10.1186/1742-6405-11-9, Hassan 2014 {published data only}  ,included,CD013080-bbs2-0019,,,24456757,95.0,https://aidsrestherapy.biomedcentral.com/counter/pdf/10.1186/1742-6405-11-9,,24456757
CD013080-bib-0020,"Jayaweera DT, Scerpella E, Robinson M, Rode R, Campo R, Rodriguez A, et al. ",The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study, International Journal of STD & AIDS ,2003,14,    ,['citation-journal']," Jayaweera DT, Scerpella E, Robinson M, Rode R, Campo R, Rodriguez A, et al. The safety and efficacy of indinavir and ritonavir (400/400 mg BID) in HIV-1-infected individuals from an inner-city minority population: a pilot study.  International Journal of STD & AIDS 2003;14(11):732-6. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1258/09564620360719750', 'https://www.ncbi.nlm.nih.gov/pubmed/14624734', 'https://scholar.google.com/scholar_lookup?title=The+safety+and+efficacy+of+indinavir+and+ritonavir+(400/400+mg+BID)+in+HIV-1-infected+individuals+from+an+inner-city+minority+population:+a+pilot+study+&author=DT+Jayaweera&author=E+Scerpella&author=M+Robinson&author=R+Rode&author=R+Campo&author=A+Rodriguez&publication_year=2003&hl=en']",14624734,https://doi.org/10.1258/09564620360719750, Jayaweera 2003 {published data only}  ,included,CD013080-bbs2-0020,,14624734,14624734,4.0,,,14624734
CD013080-bib-0021,"Jiamsakul A, Sungkanuparph S, Law M, Kantor R, Praparattanapan J, Li PC, et al. ",HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia, Journal of the International AIDS Society ,2014,17,    ,['citation-journal']," Jiamsakul A, Sungkanuparph S, Law M, Kantor R, Praparattanapan J, Li PC, et al. HIV multi-drug resistance at first-line antiretroviral failure and subsequent virological response in Asia.  Journal of the International AIDS Society 2014;17:19053. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.7448/IAS.17.1.19053', 'https://www.ncbi.nlm.nih.gov/pubmed/25141905', 'https://scholar.google.com/scholar_lookup?title=HIV+multi-drug+resistance+at+first-line+antiretroviral+failure+and+subsequent+virological+response+in+Asia+&author=A+Jiamsakul&author=S+Sungkanuparph&author=M+Law&author=R+Kantor&author=J+Praparattanapan&author=PC+Li&publication_year=2014&hl=en']",25141905,https://doi.org/10.7448/IAS.17.1.19053, Jiamsakul 2014 {published data only}  ,included,CD013080-bbs2-0021,,25141905,25141905,18.0,https://europepmc.org/articles/pmc4139921?pdf=render,,25141905
CD013080-bib-0022,"Kitkungvan D, Apisarnthanarak A, Laowansiri P, Mundy LM. ",Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense, HIV Medicine ,2008,9,    ,['citation-journal']," Kitkungvan D, Apisarnthanarak A, Laowansiri P, Mundy LM. Secure antiretroviral therapy delivery in a resource-limited setting: streamlined to minimize drug resistance and expense.  HIV Medicine 2008;9(8):636-41. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/j.1468-1293.2008.00611.x', 'https://www.ncbi.nlm.nih.gov/pubmed/18643857', 'https://scholar.google.com/scholar_lookup?title=Secure+antiretroviral+therapy+delivery+in+a+resource-limited+setting:+streamlined+to+minimize+drug+resistance+and+expense+&author=D+Kitkungvan&author=A+Apisarnthanarak&author=P+Laowansiri&author=LM+Mundy&publication_year=2008&hl=en']",18643857,https://doi.org/10.1111/j.1468-1293.2008.00611.x, Kitkungvan 2008 {published data only}  ,included,CD013080-bbs2-0022,,,18643857,9.0,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1468-1293.2008.00611.x,,18643857
CD013080-bib-0023,"Labhardt ND, Lejone T, Setoko M, Poka M, Ehmer J, Pfeiffer K, et al. ",A clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings - experience from Lesotho, PLOS One ,2012,7,    ,['citation-journal']," Labhardt ND, Lejone T, Setoko M, Poka M, Ehmer J, Pfeiffer K, et al. A clinical prediction score in addition to WHO criteria for anti-retroviral treatment failure in resource-limited settings - experience from Lesotho.  PLOS One 2012;7(10):e47937. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0047937', 'https://www.ncbi.nlm.nih.gov/pubmed/23118910', 'https://scholar.google.com/scholar_lookup?title=A+clinical+prediction+score+in+addition+to+WHO+criteria+for+anti-retroviral+treatment+failure+in+resource-limited+settings+-+experience+from+Lesotho+&author=ND+Labhardt&author=T+Lejone&author=M+Setoko&author=M+Poka&author=J+Ehmer&author=K+Pfeiffer&publication_year=2012&hl=en']",23118910,https://doi.org/10.1371/journal.pone.0047937, Labhardt 2012 {published data only}  ,included,CD013080-bbs2-0023,,23118910,23118910,20.0,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0047937&type=printable,,23118910
CD013080-bib-0024,"Landes M, Van Lettow M, Van Oosterhout JJ, Schouten E, Auld A, Kalua T, et al. ",Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: implications for the elimination of infant transmission, PLOS One ,2021,16,    ,['citation-journal']," Landes M, Van Lettow M, Van Oosterhout JJ, Schouten E, Auld A, Kalua T, et al. Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: implications for the elimination of infant transmission.  PLOS One 2021;16(3):e0248559. CENTRAL [DOI: doi.org/10.1371/journal.pone.0248559]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0248559', 'https://www.ncbi.nlm.nih.gov/pubmed/33711066', 'https://scholar.google.com/scholar_lookup?title=Early+post-partum+viremia+predicts+long-term+non-suppression+of+viral+load+in+HIV-positive+women+on+ART+in+Malawi:+implications+for+the+elimination+of+infant+transmission+&author=M+Landes&author=M+VanLettow&author=JJ+VanOosterhout&author=E+Schouten&author=A+Auld&author=T+Kalua&publication_year=2021&hl=en']",33711066,https://doi.org/10.1371/journal.pone.0248559, Landes 2021 {published data only}  ,included,CD013080-bbs2-0024,,33711066,33711066,13.0,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0248559&type=printable,,33711066
CD013080-bib-0025,"Mariana N, Lisdawati V, Maemun S, Sucahyo A, Debby P, Yuli, et al. ","Evaluation of adherence, virology and immunology response in HIV patients treated with a once daily fixed dose combination (FDC) and a free combination of antiretroviral", Advanced Science Letters ,2018,24,    ,['citation-journal']," Mariana N, Lisdawati V, Maemun S, Sucahyo A, Debby P, Yuli, et al. Evaluation of adherence, virology and immunology response in HIV patients treated with a once daily fixed dose combination (FDC) and a free combination of antiretroviral.  Advanced Science Letters 2018;24(8):6143-6. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.1166/asl.2018.12656', 'https://scholar.google.com/scholar_lookup?title=Evaluation+of+adherence,+virology+and+immunology+response+in+HIV+patients+treated+with+a+once+daily+fixed+dose+combination+(FDC)+and+a+free+combination+of+antiretroviral+&author=N+Mariana&author=V+Lisdawati&author=S+Maemun&author=A+Sucahyo&author=P+Debby&publication_year=2018&hl=en']",,https://doi.org/10.1166/asl.2018.12656, Mariana 2018 {published data only}  ,included,CD013080-bbs2-0025,,,,1.0,,,
CD013080-bib-0026,"Mbengue MAS, Chasela C, Onoya D, Mboup S, Fox MP, Evans D. ","Clinical predictor score to identify patients at risk of poor viral load suppression at six months on antiretroviral therapy: results from a prospective cohort study in Johannesburg, South Africa", Clinical Epidemiology ,2019,11,    ,['citation-journal']," Mbengue MAS, Chasela C, Onoya D, Mboup S, Fox MP, Evans D. Clinical predictor score to identify patients at risk of poor viral load suppression at six months on antiretroviral therapy: results from a prospective cohort study in Johannesburg, South Africa.  Clinical Epidemiology 2019;11:359-73. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.2147/CLEP.S197741', 'https://www.ncbi.nlm.nih.gov/pubmed/31191029', 'https://scholar.google.com/scholar_lookup?title=Clinical+predictor+score+to+identify+patients+at+risk+of+poor+viral+load+suppression+at+six+months+on+antiretroviral+therapy:+results+from+a+prospective+cohort+study+in+Johannesburg,+South+Africa+&author=MAS+Mbengue&author=C+Chasela&author=D+Onoya&author=S+Mboup&author=MP+Fox&author=D+Evans&publication_year=2019&hl=en']",31191029,https://doi.org/10.2147/CLEP.S197741, Mbengue 2019 {published data only}  ,included,CD013080-bbs2-0026,,,31191029,16.0,https://www.dovepress.com/getfile.php?fileID=49678,,31191029
CD013080-bib-0027,"McMahon JH, Manoharan A, Wanke CA, Mammen S, Jose H, Malini T, et al. ","Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India", AIDS and Behavior ,2013,17,    ,['citation-journal']," McMahon JH, Manoharan A, Wanke CA, Mammen S, Jose H, Malini T, et al. Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India.  AIDS and Behavior 2013;17(6):2253-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1007/s10461-013-0436-x', 'https://www.ncbi.nlm.nih.gov/pubmed/23435750', 'https://scholar.google.com/scholar_lookup?title=Pharmacy+and+self-report+adherence+measures+to+predict+virological+outcomes+for+patients+on+free+antiretroviral+therapy+in+Tamil+Nadu,+India+&author=JH+McMahon&author=A+Manoharan&author=CA+Wanke&author=S+Mammen&author=H+Jose&author=T+Malini&publication_year=2013&hl=en']",23435750,https://doi.org/10.1007/s10461-013-0436-x, McMahon 2013 {published data only}  ,included,CD013080-bbs2-0027,,,23435750,21.0,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674125,,23435750
CD013080-bib-0028,"Messou E, Chaix ML, Gabillard D, Minga A, Losina E, Yapo V, et al. ","Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Cote d'Ivoire", Journal of Acquired Immune Deficiency Syndromes ,2011,56,    ,['citation-journal']," Messou E, Chaix ML, Gabillard D, Minga A, Losina E, Yapo V, et al. Association between medication possession ratio, virologic failure and drug resistance in HIV-1-infected adults on antiretroviral therapy in Cote d'Ivoire.  Journal of Acquired Immune Deficiency Syndromes 2011;56(4):356-64. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAI.0b013e3182084b5a', 'https://www.ncbi.nlm.nih.gov/pubmed/21191309', ""https://scholar.google.com/scholar_lookup?title=Association+between+medication+possession+ratio,+virologic+failure+and+drug+resistance+in+HIV-1-infected+adults+on+antiretroviral+therapy+in+Cote+d'Ivoire+&author=E+Messou&author=ML+Chaix&author=D+Gabillard&author=A+Minga&author=E+Losina&author=V+Yapo&publication_year=2011&hl=en""]",21191309,https://doi.org/10.1097/QAI.0b013e3182084b5a, Messou 2011 {published data only}  ,included,CD013080-bbs2-0028,,21191309,21191309,83.0,"https://journals.lww.com/jaids/fulltext/2011/04010/association_between_medication_possession_ratio,.11.aspx",,21191309
CD013080-bib-0029,"Meya D, Spacek LA, Tibenderana H, John L, Namugga I, Magero S, et al. ","Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria", Journal of the International AIDS Society ,2009,12,    ,['citation-journal']," Meya D, Spacek LA, Tibenderana H, John L, Namugga I, Magero S, et al. Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria.  Journal of the International AIDS Society 2009;12:3. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1758-2652-12-3', 'https://www.ncbi.nlm.nih.gov/pubmed/19261189', 'https://scholar.google.com/scholar_lookup?title=Development+and+evaluation+of+a+clinical+algorithm+to+monitor+patients+on+antiretrovirals+in+resource-limited+settings+using+adherence,+clinical+and+CD4+cell+count+criteria+&author=D+Meya&author=LA+Spacek&author=H+Tibenderana&author=L+John&author=I+Namugga&author=S+Magero&publication_year=2009&hl=en']",19261189,https://doi.org/10.1186/1758-2652-12-3, Meya 2009 {published data only}  ,included,CD013080-bbs2-0029,,19261189,19261189,52.0,https://onlinelibrary.wiley.com/doi/pdfdirect/10.1186/1758-2652-12-3,,19261189
CD013080-bib-0030,"Mogosetsi NJ, Mabuza LH, Ogunbanjo GA. ","The prevalence of HIV load suppression and related factors among patients on ART at Phedisong 4 Clinic, Pretoria, South Africa", Open Public Health Journal ,2018,11,    ,['citation-journal']," Mogosetsi NJ, Mabuza LH, Ogunbanjo GA. The prevalence of HIV load suppression and related factors among patients on ART at Phedisong 4 Clinic, Pretoria, South Africa.  Open Public Health Journal 2018;11:135-46. CENTRAL    Link to article     Google Scholar     ","['', 'https://doi.org/10.2174/1874944501811010135', 'https://scholar.google.com/scholar_lookup?title=The+prevalence+of+HIV+load+suppression+and+related+factors+among+patients+on+ART+at+Phedisong+4+Clinic,+Pretoria,+South+Africa+&author=NJ+Mogosetsi&author=LH+Mabuza&author=GA+Ogunbanjo&publication_year=2018&hl=en']",,https://doi.org/10.2174/1874944501811010135, Mogosetsi 2018 {published data only}  ,included,CD013080-bbs2-0030,,,,12.0,https://openpublichealthjournal.com/VOLUME/11/PAGE/135/PDF/,,
CD013080-bib-0031,"Moosa A, Gengiah TN, Lewis L, Naidoo K. ",Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study, BMC Infectious Diseases ,2019,19,    ,['citation-journal']," Moosa A, Gengiah TN, Lewis L, Naidoo K. Long-term adherence to antiretroviral therapy in a South African adult patient cohort: a retrospective study.  BMC Infectious Diseases 2019;19:775. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/s12879-019-4410-8', 'https://www.ncbi.nlm.nih.gov/pubmed/31488063', 'https://scholar.google.com/scholar_lookup?title=Long-term+adherence+to+antiretroviral+therapy+in+a+South+African+adult+patient+cohort:+a+retrospective+study+&author=A+Moosa&author=TN+Gengiah&author=L+Lewis&author=K+Naidoo&publication_year=2019&hl=en']",31488063,https://doi.org/10.1186/s12879-019-4410-8, Moosa 2019 {published data only}  ,included,CD013080-bbs2-0031,,,31488063,86.0,https://bmcinfectdis.biomedcentral.com/track/pdf/10.1186/s12879-019-4410-8,,31488063
CD013080-bib-0032,"Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, et al. ",Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study, PLOS One ,2014,9,    ,['citation-journal']," Mutwa PR, Boer KR, Asiimwe-Kateera B, Tuyishimire D, Muganga N, Lange JM, et al. Safety and effectiveness of combination antiretroviral therapy during the first year of treatment in HIV-1 infected Rwandan children: a prospective study.  PLOS One 2014;9(11):e111948. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0111948', 'https://www.ncbi.nlm.nih.gov/pubmed/25365302', 'https://scholar.google.com/scholar_lookup?title=Safety+and+effectiveness+of+combination+antiretroviral+therapy+during+the+first+year+of+treatment+in+HIV-1+infected+Rwandan+children:+a+prospective+study+&author=PR+Mutwa&author=KR+Boer&author=B+Asiimwe-Kateera&author=D+Tuyishimire&author=N+Muganga&author=JM+Lange&publication_year=2014&hl=en']",25365302,https://doi.org/10.1371/journal.pone.0111948, Mutwa 2014 {published data only}  ,included,CD013080-bbs2-0032,,25365302,25365302,27.0,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0111948&type=printable,,25365302
CD013080-bib-0033,"Navarro J, Perez M, Curran A, Burgos J, Feijoo M, Torrella A, et al. ",Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain, AIDS Patient Care and STDs ,2014,28,    ,['citation-journal']," Navarro J, Perez M, Curran A, Burgos J, Feijoo M, Torrella A, et al. Impact of an adherence program to antiretroviral treatment on virologic response in a cohort of multitreated and poorly adherent HIV-infected patients in Spain.  AIDS Patient Care and STDs 2014;28(10):537-42. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1089/apc.2014.0097', 'https://www.ncbi.nlm.nih.gov/pubmed/25111167', 'https://scholar.google.com/scholar_lookup?title=Impact+of+an+adherence+program+to+antiretroviral+treatment+on+virologic+response+in+a+cohort+of+multitreated+and+poorly+adherent+HIV-infected+patients+in+Spain+&author=J+Navarro&author=M+Perez&author=A+Curran&author=J+Burgos&author=M+Feijoo&author=A+Torrella&publication_year=2014&hl=en']",25111167,https://doi.org/10.1089/apc.2014.0097, Navarro 2014 {published data only}  ,included,CD013080-bbs2-0033,,,25111167,9.0,,,25111167
CD013080-bib-0034,"Nelson M, Girard PM, Demasi R, Chen L, Smets E, Sekar V, et al. ","Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data", Journal of Antimicrobial Chemotherapy ,2010,65,    ,['citation-journal']," Nelson M, Girard PM, Demasi R, Chen L, Smets E, Sekar V, et al. Suboptimal adherence to darunavir/ritonavir has minimal effect on efficacy compared with lopinavir/ritonavir in treatment-naive, HIV-infected patients: 96 week ARTEMIS data.  Journal of Antimicrobial Chemotherapy 2010;65(7):1505-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/jac/dkq150', 'https://www.ncbi.nlm.nih.gov/pubmed/20498120', 'https://scholar.google.com/scholar_lookup?title=Suboptimal+adherence+to+darunavir/ritonavir+has+minimal+effect+on+efficacy+compared+with+lopinavir/ritonavir+in+treatment-naive,+HIV-infected+patients:+96+week+ARTEMIS+data+&author=M+Nelson&author=PM+Girard&author=R+Demasi&author=L+Chen&author=E+Smets&author=V+Sekar&publication_year=2010&hl=en']",20498120,https://doi.org/10.1093/jac/dkq150, Nelson 2010 {published data only}  ,included,CD013080-bbs2-0034,,20498120,20498120,72.0,https://academic.oup.com/jac/article-pdf/65/7/1505/2369615/dkq150.pdf,,20498120
CD013080-bib-0035,"Oette M, Kroidl A, Göbels K, Stabbert A, Menge M, Sagir A, et al. ",Predictors of short-term success of antiretroviral therapy in HIV infection, Journal of Antimicrobial Chemotherapy ,2006,58,    ,['citation-journal']," Oette M, Kroidl A, Göbels K, Stabbert A, Menge M, Sagir A, et al. Predictors of short-term success of antiretroviral therapy in HIV infection.  Journal of Antimicrobial Chemotherapy 2006;58(1):147-53. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/jac/dkl189', 'https://www.ncbi.nlm.nih.gov/pubmed/16687458', 'https://scholar.google.com/scholar_lookup?title=Predictors+of+short-term+success+of+antiretroviral+therapy+in+HIV+infection&author=M+Oette&author=A+Kroidl&author=K+Göbels&author=A+Stabbert&author=M+Menge&author=A+Sagir&publication_year=2006&hl=en']",16687458,https://doi.org/10.1093/jac/dkl189, Oette 2006 {published data only}  ,included,CD013080-bbs2-0035,,,16687458,23.0,https://academic.oup.com/jac/article-pdf/58/1/147/2168282/dkl189.pdf,,16687458
CD013080-bib-0036,"Okonji JA, Zeh C, Weidle PJ, Williamson J, Akoth B, Masaba RO, et al. ","CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya", Journal of Acquired Immune Deficiency Syndromes ,2012,61,    ,['citation-journal']," Okonji JA, Zeh C, Weidle PJ, Williamson J, Akoth B, Masaba RO, et al. CD4, viral load response, and adherence among antiretroviral-naive breast-feeding women receiving triple antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV in Kisumu, Kenya.  Journal of Acquired Immune Deficiency Syndromes 2012;61(2):249-57. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAI.0b013e318262514f', 'https://www.ncbi.nlm.nih.gov/pubmed/22692094', 'https://scholar.google.com/scholar_lookup?title=CD4,+viral+load+response,+and+adherence+among+antiretroviral-naive+breast-feeding+women+receiving+triple+antiretroviral+prophylaxis+for+prevention+of+mother-to-child+transmission+of+HIV+in+Kisumu,+Kenya+&author=JA+Okonji&author=C+Zeh&author=PJ+Weidle&author=J+Williamson&author=B+Akoth&author=RO+Masaba&publication_year=2012&hl=en']",22692094,https://doi.org/10.1097/QAI.0b013e318262514f, Okonji 2012 {published data only}  ,included,CD013080-bbs2-0036,,22692094,22692094,58.0,https://doi.org/10.1097/qai.0b013e318262514f,,22692094
CD013080-bib-0037,"Orrell C, Bangsberg DR, Badri M, Wood R. ",Adherence is not a barrier to successful antiretroviral therapy in South Africa, AIDS ,2003,17,    ,['citation-journal']," Orrell C, Bangsberg DR, Badri M, Wood R. Adherence is not a barrier to successful antiretroviral therapy in South Africa.  AIDS 2003;17(9):1369-75. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/00002030-200306130-00011', 'https://www.ncbi.nlm.nih.gov/pubmed/12799558', 'https://scholar.google.com/scholar_lookup?title=Adherence+is+not+a+barrier+to+successful+antiretroviral+therapy+in+South+Africa&author=C+Orrell&author=DR+Bangsberg&author=M+Badri&author=R+Wood&publication_year=2003&hl=en']",12799558,https://doi.org/10.1097/00002030-200306130-00011, Orrell 2003 {published data only}  ,included,CD013080-bbs2-0037,,,12799558,411.0,https://journals.lww.com/aidsonline/fulltext/2003/06130/adherence_is_not_a_barrier_to_successful.11.aspx,,12799558
CD013080-bib-0038,"Orrell C, Cohen K, Leisegang R, Bangsberg DR, Wood R, Maartens G. ",Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?, AIDS Research and Therapy ,2017,14,    ,['citation-journal']," Orrell C, Cohen K, Leisegang R, Bangsberg DR, Wood R, Maartens G. Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes? AIDS Research and Therapy 2017;14(1):20. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/s12981-017-0138-y', 'https://www.ncbi.nlm.nih.gov/pubmed/28376815', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+six+methods+to+estimate+adherence+in+an+ART-naïve+cohort+in+a+resource-poor+setting:+which+best+predicts+virological+and+resistance+outcomes?+&author=C+Orrell&author=K+Cohen&author=R+Leisegang&author=DR+Bangsberg&author=R+Wood&author=G+Maartens&publication_year=2017&hl=en']",28376815,https://doi.org/10.1186/s12981-017-0138-y, Orrell 2017 {published data only}  ,included,CD013080-bbs2-0038,,,28376815,67.0,https://aidsrestherapy.biomedcentral.com/track/pdf/10.1186/s12981-017-0138-y,,28376815
CD013080-bib-0039,"Ortega L, Cuevas MJ, Pérez-Simón R, Villares C, Alcoba M, Martín V. ",Factors predicting detectable viral load in patients with highly active antiretroviral treatment, Medicina Clínica ,2004,123,    ,['citation-journal']," Ortega L, Cuevas MJ, Pérez-Simón R, Villares C, Alcoba M, Martín V. Factors predicting detectable viral load in patients with highly active antiretroviral treatment [Factores predictores de carga viral detectable en pacientes en tratamiento antirretroviral de gran actividad].  Medicina Clínica 2004;123(2):45-9. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1016/S0025-7753(04)74407-3', 'https://www.ncbi.nlm.nih.gov/pubmed/15225482', 'https://scholar.google.com/scholar_lookup?title=Factors+predicting+detectable+viral+load+in+patients+with+highly+active+antiretroviral+treatment+&author=L+Ortega&author=MJ+Cuevas&author=R+Pérez-Simón&author=C+Villares&author=M+Alcoba&author=V+Martín&publication_year=2004&hl=en']",15225482,https://doi.org/10.1016/S0025-7753(04)74407-3, Ortega 2004 {published data only}  ,included,CD013080-bbs2-0039,15225482,,,3.0,,,15225482
CD013080-bib-0040,"Paolillo EW, Gongvatana A, Umlauf A, Letendre SL, Moore DJ. ",At-risk alcohol use is associated with antiretroviral treatment nonadherence among adults living with HIV/AIDS," Alcoholism, Clinical and Experimental Research ",2017,41,    ,['citation-journal']," Paolillo EW, Gongvatana A, Umlauf A, Letendre SL, Moore DJ. At-risk alcohol use is associated with antiretroviral treatment nonadherence among adults living with HIV/AIDS.  Alcoholism, Clinical and Experimental Research 2017;41(8):1518-25. CENTRAL [DOI: 10.1111/acer.13433]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1111/acer.13433', 'https://www.ncbi.nlm.nih.gov/pubmed/28679147', 'https://scholar.google.com/scholar_lookup?title=At-risk+alcohol+use+is+associated+with+antiretroviral+treatment+nonadherence+among+adults+living+with+HIV/AIDS+&author=EW+Paolillo&author=A+Gongvatana&author=A+Umlauf&author=SL+Letendre&author=DJ+Moore&publication_year=2017&hl=en']",28679147,https://doi.org/10.1111/acer.13433, Paolillo 2017 {published data only}  ,included,CD013080-bbs2-0040,28679147,,28679147,24.0,https://europepmc.org/articles/pmc5564671?pdf=render,,28679147
CD013080-bib-0041,"Parienti JJ, Ragland K, Lucht F, De la Blanchardière A, Dargère S, Yazdanpanah Y, et al. ","Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication", Clinical Infectious Diseases ,2010,50,    ,['citation-journal']," Parienti JJ, Ragland K, Lucht F, De la Blanchardière A, Dargère S, Yazdanpanah Y, et al. Average adherence to boosted protease inhibitor therapy, rather than the pattern of missed doses, as a predictor of HIV RNA replication.  Clinical Infectious Diseases 2010;50(8):1192-7. CENTRAL [DOI: 10.1086/651419]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1086/651419', 'https://www.ncbi.nlm.nih.gov/pubmed/20210643', 'https://scholar.google.com/scholar_lookup?title=Average+adherence+to+boosted+protease+inhibitor+therapy,+rather+than+the+pattern+of+missed+doses,+as+a+predictor+of+HIV+RNA+replication+&author=JJ+Parienti&author=K+Ragland&author=F+Lucht&author=A+DelaBlanchardière&author=S+Dargère&author=Y+Yazdanpanah&publication_year=2010&hl=en']",20210643,https://doi.org/10.1086/651419, Parienti 2010 {published data only}  ,included,CD013080-bbs2-0041,,,20210643,107.0,https://academic.oup.com/cid/article-pdf/50/8/1192/1232886/50-8-1192.pdf,,20210643
CD013080-bib-0042,"Parker RA, Rabideau DJ, Sax PE, Tierney C, Daar ES, Collier AC, et al. ","Impact of medication adherence on virologic failure in A5202: a randomized, partially blinded, phase 3B study", Clinical Infectious Diseases ,2017,64,    ,['citation-journal']," Parker RA, Rabideau DJ, Sax PE, Tierney C, Daar ES, Collier AC, et al. Impact of medication adherence on virologic failure in A5202: a randomized, partially blinded, phase 3B study.  Clinical Infectious Diseases 2017;64(11):1612-4. CENTRAL [DOI: 10.1093/cid/cix176]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1093/cid/cix176', 'https://www.ncbi.nlm.nih.gov/pubmed/28329243', 'https://scholar.google.com/scholar_lookup?title=Impact+of+medication+adherence+on+virologic+failure+in+A5202:+a+randomized,+partially+blinded,+phase+3B+study+&author=RA+Parker&author=DJ+Rabideau&author=PE+Sax&author=C+Tierney&author=ES+Daar&author=AC+Collier&publication_year=2017&hl=en']",28329243,https://doi.org/10.1093/cid/cix176, Parker 2017 {published data only}  ,included,CD013080-bbs2-0042,,28329243,28329243,9.0,https://academic.oup.com/cid/article-pdf/64/11/1612/17844223/cix176.pdf,,28329243
CD013080-bib-0043,"Pasquau J, Hidalgo-Tenorio C, Montes ML, Romero-Palacios A, Vergas J, Sanjoaquín I, et al. ","High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: a randomized clinical trial", PLOS One ,2018,13,    ,['citation-journal']," Pasquau J, Hidalgo-Tenorio C, Montes ML, Romero-Palacios A, Vergas J, Sanjoaquín I, et al. High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: a randomized clinical trial.  PLOS One 2018;13(4):e0195068. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1371/journal.pone.0195068', 'https://www.ncbi.nlm.nih.gov/pubmed/29649309', 'https://scholar.google.com/scholar_lookup?title=High+quality+of+life,+treatment+tolerability,+safety+and+efficacy+in+HIV+patients+switching+from+triple+therapy+to+lopinavir/ritonavir+monotherapy:+a+randomized+clinical+trial+&author=J+Pasquau&author=C+Hidalgo-Tenorio&author=ML+Montes&author=A+Romero-Palacios&author=J+Vergas&author=I+Sanjoaquín&publication_year=2018&hl=en']",29649309,https://doi.org/10.1371/journal.pone.0195068, Pasquau 2018 {published data only}  ,included,CD013080-bbs2-0043,,29649309,29649309,21.0,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0195068&type=printable,,29649309
CD013080-bib-0044,"Phillips TK, Sinxadi P, Abrams EJ, Zerbe A, Orrell C, Hu NC, et al. ","A comparison of plasma efavirenz and tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African women", Journal of Acquired Immune Deficiency Syndromes ,2019,81,    ,['citation-journal']," Phillips TK, Sinxadi P, Abrams EJ, Zerbe A, Orrell C, Hu NC, et al. A comparison of plasma efavirenz and tenofovir, dried blood spot tenofovir-diphosphate, and self-reported adherence to predict virologic suppression among South African women.  Journal of Acquired Immune Deficiency Syndromes 2019;81(3):311-8. CENTRAL [DOI: 10.1097/QAI.0000000000002032]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAI.0000000000002032', 'https://www.ncbi.nlm.nih.gov/pubmed/30893125', 'https://scholar.google.com/scholar_lookup?title=A+comparison+of+plasma+efavirenz+and+tenofovir,+dried+blood+spot+tenofovir-diphosphate,+and+self-reported+adherence+to+predict+virologic+suppression+among+South+African+women+&author=TK+Phillips&author=P+Sinxadi&author=EJ+Abrams&author=A+Zerbe&author=C+Orrell&author=NC+Hu&publication_year=2019&hl=en']",30893125,https://doi.org/10.1097/QAI.0000000000002032, Phillips 2019 {published data only}  ,included,CD013080-bbs2-0044,,30893125,30893125,31.0,https://doi.org/10.1097/qai.0000000000002032,,30893125
CD013080-bib-0045,"Pulido F, Pérez-Valero I, Delgado R, Arranz A, Pasquau J, Portilla J, et al. ",Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression, Antiviral Therapy ,2009,14,    ,['citation-journal']," Pulido F, Pérez-Valero I, Delgado R, Arranz A, Pasquau J, Portilla J, et al. Risk factors for loss of virological suppression in patients receiving lopinavir/ritonavir monotherapy for maintenance of HIV suppression.  Antiviral Therapy 2009;14(2):195-201. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1177/135965350901400210', 'https://www.ncbi.nlm.nih.gov/pubmed/19430094', 'https://scholar.google.com/scholar_lookup?title=Risk+factors+for+loss+of+virological+suppression+in+patients+receiving+lopinavir/ritonavir+monotherapy+for+maintenance+of+HIV+suppression+&author=F+Pulido&author=I+Pérez-Valero&author=R+Delgado&author=A+Arranz&author=J+Pasquau&author=J+Portilla&publication_year=2009&hl=en']",19430094,https://doi.org/10.1177/135965350901400210, Pulido 2009 {published data only}  ,included,CD013080-bbs2-0045,,19430094,19430094,72.0,https://journals.sagepub.com/doi/pdf/10.1177/135965350901400210,,19430094
CD013080-bib-0046,"Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, et al. ",Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings, BMC Public Health ,2014,14,    ,['citation-journal']," Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, et al. Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings.  BMC Public Health 2014;14:1035. CENTRAL [DOI: 10.1186/1471-2458-14-1035]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1186/1471-2458-14-1035', 'https://www.ncbi.nlm.nih.gov/pubmed/25280535', 'https://scholar.google.com/scholar_lookup?title=Pharmacy+refill+adherence+outperforms+self-reported+methods+in+predicting+HIV+therapy+outcome+in+resource-limited+settings+&author=RZ+Sangeda&author=F+Mosha&author=M+Prosperi&author=S+Aboud&author=J+Vercauteren&author=RJ+Camacho&publication_year=2014&hl=en']",25280535,https://doi.org/10.1186/1471-2458-14-1035, Sangeda 2014 {published data only}  ,included,CD013080-bbs2-0046,,25280535,25280535,101.0,https://bmcpublichealth.biomedcentral.com/counter/pdf/10.1186/1471-2458-14-1035,,25280535
CD013080-bib-0047,"Segeral O, Madec Y, Ban B, Ouk V, Hak CR, Le Tiec C, et al. ",Simplified assessment of antiretroviral adherence and prediction of virological efficacy in HIV-infected patients in Cambodia, AIDS Research and Treatment ,2010,2010,    ,['citation-journal']," Segeral O, Madec Y, Ban B, Ouk V, Hak CR, Le Tiec C, et al. Simplified assessment of antiretroviral adherence and prediction of virological efficacy in HIV-infected patients in Cambodia.  AIDS Research and Treatment 2010;2010:142076. CENTRAL [DOI: 10.1155/2010/142076]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1155/2010/142076', 'https://www.ncbi.nlm.nih.gov/pubmed/21490902', 'https://scholar.google.com/scholar_lookup?title=Simplified+assessment+of+antiretroviral+adherence+and+prediction+of+virological+efficacy+in+HIV-infected+patients+in+Cambodia+&author=O+Segeral&author=Y+Madec&author=B+Ban&author=V+Ouk&author=CR+Hak&author=C+LeTiec&publication_year=2010&hl=en']",21490902,https://doi.org/10.1155/2010/142076, Segeral 2010 {published data only}  ,included,CD013080-bbs2-0047,,21490902,21490902,29.0,https://doi.org/10.1155/2010/142076,,21490902
CD013080-bib-0048,"Ségéral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, et al. ",Positive virological outcomes of HIV-infected patients on protease inhibitor-based second-line regimen in Cambodia: the ANRS 12276 2PICAM study, Frontiers in Public Health ,2018,6,    ,['citation-journal']," Ségéral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, et al. Positive virological outcomes of HIV-infected patients on protease inhibitor-based second-line regimen in Cambodia: the ANRS 12276 2PICAM study.  Frontiers in Public Health 2018;6:63. CENTRAL [DOI: 10.3389/fpubh.2018.00063]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.3389/fpubh.2018.00063', 'https://www.ncbi.nlm.nih.gov/pubmed/29662875', 'https://scholar.google.com/scholar_lookup?title=Positive+virological+outcomes+of+HIV-infected+patients+on+protease+inhibitor-based+second-line+regimen+in+Cambodia:+the+ANRS+12276+2PICAM+study+&author=O+Ségéral&author=E+Nerrienet&author=S+Neth&author=B+Spire&author=V+Khol&author=L+Ferradini&publication_year=2018&hl=en']",29662875,https://doi.org/10.3389/fpubh.2018.00063, Segeral 2018 {published data only}  ,included,CD013080-bbs2-0048,,29662875,29662875,7.0,https://www.frontiersin.org/articles/10.3389/fpubh.2018.00063/pdf,,29662875
CD013080-bib-0049,"Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, et al. ",Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment, Antiviral Therapy ,2008,13,    ,['citation-journal']," Spire B, Carrieri P, Sopha P, Protopopescu C, Prak N, Quillet C, et al. Adherence to antiretroviral therapy in patients enrolled in a comprehensive care program in Cambodia: a 24-month follow-up assessment.  Antiviral Therapy 2008;13(5):697-703. CENTRAL    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1177/135965350801300509', 'https://www.ncbi.nlm.nih.gov/pubmed/18771053', 'https://scholar.google.com/scholar_lookup?title=Adherence+to+antiretroviral+therapy+in+patients+enrolled+in+a+comprehensive+care+program+in+Cambodia:+a+24-month+follow-up+assessment+&author=B+Spire&author=P+Carrieri&author=P+Sopha&author=C+Protopopescu&author=N+Prak&author=C+Quillet&publication_year=2008&hl=en']",18771053,https://doi.org/10.1177/135965350801300509, Spire 2008 {published data only}  ,included,CD013080-bbs2-0049,,,18771053,54.0,https://journals.sagepub.com/doi/pdf/10.1177/135965350801300509,,18771053
CD013080-bib-0050,"Tabb ZJ, Mmbaga BT, Gandhi M, Louie A, Kuncze K, Okochi H, et al. ",Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania, AIDS ,2018,32,    ,['citation-journal']," Tabb ZJ, Mmbaga BT, Gandhi M, Louie A, Kuncze K, Okochi H, et al. Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.  AIDS 2018;32(9):1115-23. CENTRAL [DOI: 10.1097/QAD.0000000000001788]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.1097/QAD.0000000000001788', 'https://www.ncbi.nlm.nih.gov/pubmed/29438196', 'https://scholar.google.com/scholar_lookup?title=Antiretroviral+drug+concentrations+in+hair+are+associated+with+virologic+outcomes+among+young+people+living+with+HIV+in+Tanzania+&author=ZJ+Tabb&author=BT+Mmbaga&author=M+Gandhi&author=A+Louie&author=K+Kuncze&author=H+Okochi&publication_year=2018&hl=en']",29438196,https://doi.org/10.1097/QAD.0000000000001788, Tabb 2018 {published data only}  ,included,CD013080-bbs2-0050,,,29438196,30.0,https://europepmc.org/articles/pmc5945296?pdf=render,,29438196
CD013080-bib-0051,"Zoufaly A, Fillekes Q, Hammerl R, Nassimi N, Jochum J, Drexler JF, et al. ",Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study, Antiviral Therapy ,2013,18,    ,['citation-journal']," Zoufaly A, Fillekes Q, Hammerl R, Nassimi N, Jochum J, Drexler JF, et al. Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.  Antiviral Therapy 2013;18(5):681-90. CENTRAL [DOI: 10.3851/IMP2562]    Link to article     PubMed     Google Scholar     ","['', 'https://doi.org/10.3851/IMP2562', 'https://www.ncbi.nlm.nih.gov/pubmed/23502762', 'https://scholar.google.com/scholar_lookup?title=Prevalence+and+determinants+of+virological+failure+in+HIV-infected+children+on+antiretroviral+therapy+in+rural+Cameroon:+a+cross-sectional+study+&author=A+Zoufaly&author=Q+Fillekes&author=R+Hammerl&author=N+Nassimi&author=J+Jochum&author=JF+Drexler&publication_year=2013&hl=en']",23502762,https://doi.org/10.3851/IMP2562, Zoufaly 2013 {published data only}  ,included,CD013080-bbs2-0051,,,23502762,46.0,,,23502762
CD013080-bib-0052,"Almeida-Brasil CC, Moodie EEM, Cardoso TS, Do Nascimento E, Ceccato MDGB. ",Comparison of the predictive performance of adherence measures for virologic failure detection in people living with HIV: a systematic review and pairwise meta-analysis, AIDS Care ,2019,31,    ,['citation-journal']," Almeida-Brasil CC, Moodie EEM, Cardoso TS, Do Nascimento E, Ceccato MDGB. Comparison of the predictive performance of adherence measures for virologic failure detection in people living with HIV: a systematic review and pairwise meta-analysis.  AIDS Care 2019;31(6):647-59. [DOI: 10.1080/09540121.2018.1554241]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1080/09540121.2018.1554241', 'https://www.ncbi.nlm.nih.gov/pubmed/30516060', 'https://scholar.google.com/scholar_lookup?title=Comparison+of+the+predictive+performance+of+adherence+measures+for+virologic+failure+detection+in+people+living+with+HIV:+a+systematic+review+and+pairwise+meta-analysis+&author=CC+Almeida-Brasil&author=EEM+Moodie&author=TS+Cardoso&author=E+DoNascimento&author=MDGB+Ceccato&publication_year=2019&hl=en']",30516060,https://doi.org/10.1080/09540121.2018.1554241, Almeida‐Brasil 2019 ,additional,CD013080-bbs2-0052,,30516060,30516060,18.0,,,30516060
CD013080-bib-0053,"Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, et al. ",Provider assessment of adherence to antiretroviral therapy, Journal of Acquired Immune Deficiency Syndromes ,2001,26,    ,['citation-journal']," Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, et al. Provider assessment of adherence to antiretroviral therapy.  Journal of Acquired Immune Deficiency Syndromes 2001;26(5):435-42.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/00042560-200104150-00005', 'https://www.ncbi.nlm.nih.gov/pubmed/11391162', 'https://scholar.google.com/scholar_lookup?title=Provider+assessment+of+adherence+to+antiretroviral+therapy&author=DR+Bangsberg&author=FM+Hecht&author=H+Clague&author=ED+Charlebois&author=D+Ciccarone&author=M+Chesney&publication_year=2001&hl=en']",11391162,https://doi.org/10.1097/00042560-200104150-00005, Bangsberg 2001 ,additional,CD013080-bbs2-0053,,,11391162,194.0,https://doi.org/10.1097/00042560-200104150-00005,,11391162
CD013080-bib-0054,"Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. ",Adherence to antiretroviral therapy and virologic failure: a meta-analysis, Medicine (Baltimore) ,2016,95,    ,['citation-journal']," Bezabhe WM, Chalmers L, Bereznicki LR, Peterson GM. Adherence to antiretroviral therapy and virologic failure: a meta-analysis.  Medicine (Baltimore) 2016;95(15):e3361.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/MD.0000000000003361', 'https://www.ncbi.nlm.nih.gov/pubmed/27082595', 'https://scholar.google.com/scholar_lookup?title=Adherence+to+antiretroviral+therapy+and+virologic+failure:+a+meta-analysis&author=WM+Bezabhe&author=L+Chalmers&author=LR+Bereznicki&author=GM+Peterson&publication_year=2016&hl=en']",27082595,https://doi.org/10.1097/MD.0000000000003361, Bezabhe 2016 ,additional,CD013080-bbs2-0054,27082595,,27082595,138.0,https://doi.org/10.1097/md.0000000000003361,,27082595
CD013080-bib-0055,"Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. ",Viral load monitoring as a tool to reinforce adherence: a systematic review, Journal of Acquired Immune Deficiency Syndromes (1999) ,2013,64,    ,['citation-journal']," Bonner K, Mezochow A, Roberts T, Ford N, Cohn J. Viral load monitoring as a tool to reinforce adherence: a systematic review.  Journal of Acquired Immune Deficiency Syndromes (1999) 2013;64(1):74-8.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/QAI.0b013e31829f05ac', 'https://www.ncbi.nlm.nih.gov/pubmed/23774877', 'https://scholar.google.com/scholar_lookup?title=Viral+load+monitoring+as+a+tool+to+reinforce+adherence:+a+systematic+review&author=K+Bonner&author=A+Mezochow&author=T+Roberts&author=N+Ford&author=J+Cohn&publication_year=2013&hl=en']",23774877,https://doi.org/10.1097/QAI.0b013e31829f05ac, Bonner 2013 ,additional,CD013080-bbs2-0055,23774877,23774877,23774877,172.0,https://doi.org/10.1097/qai.0b013e31829f05ac,,23774877
CD013080-bib-0056,"Carrieri P, Cailleton V, Le Moing V, Spire B, Dellamonica P, Bouvet E, et al. ",The dynamic of adherence to highly active antiretroviral therapy: results from the French national APROCO cohort, Journal of Acquired Immune Deficiency Syndromes ,2001,28,    ,['citation-journal']," Carrieri P, Cailleton V, Le Moing V, Spire B, Dellamonica P, Bouvet E, et al. The dynamic of adherence to highly active antiretroviral therapy: results from the French national APROCO cohort.  Journal of Acquired Immune Deficiency Syndromes 2001;28(3):232-9.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/00042560-200111010-00005', 'https://www.ncbi.nlm.nih.gov/pubmed/11694829', 'https://scholar.google.com/scholar_lookup?title=The+dynamic+of+adherence+to+highly+active+antiretroviral+therapy:+results+from+the+French+national+APROCO+cohort+&author=P+Carrieri&author=V+Cailleton&author=V+LeMoing&author=B+Spire&author=P+Dellamonica&author=E+Bouvet&publication_year=2001&hl=en']",11694829,https://doi.org/10.1097/00042560-200111010-00005, Carrieri 2001 ,additional,CD013080-bbs2-0056,,11694829,11694829,205.0,,,11694829
CD013080-bib-0057,"Castillo-Mancilla JR, Haberer JE. ",Adherence measurements in HIV: new advancements in pharmacologic methods and real-time monitoring, Current HIV/AIDS Reports ,2018,15,    ,['citation-journal']," Castillo-Mancilla JR, Haberer JE. Adherence measurements in HIV: new advancements in pharmacologic methods and real-time monitoring.  Current HIV/AIDS Reports 2018;15(1):49-59.    Link to article     Google Scholar     ","['https://doi.org/10.1007/s11904-018-0377-0', 'https://scholar.google.com/scholar_lookup?title=Adherence+measurements+in+HIV:+new+advancements+in+pharmacologic+methods+and+real-time+monitoring+&author=JR+Castillo-Mancilla&author=JE+Haberer&publication_year=2018&hl=en']",,https://doi.org/10.1007/s11904-018-0377-0, Castillo‐Mancilla 2018 ,additional,CD013080-bbs2-0057,29380227,29380227,29380227,124.0,https://europepmc.org/articles/pmc5876155?pdf=render,,29380227
CD013080-bib-0058,"Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. ",Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG), AIDS Care ,2000,12,    ,['citation-journal']," Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG).  AIDS Care 2000;12(3):255-66.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1080/09540120050042891', 'https://www.ncbi.nlm.nih.gov/pubmed/10928201', 'https://scholar.google.com/scholar_lookup?title=Self-reported+adherence+to+antiretroviral+medications+among+participants+in+HIV+clinical+trials:+the+AACTG+adherence+instruments.+Patient+Care+Committee+&+Adherence+Working+Group+of+the+Outcomes+Committee+of+the+Adult+AIDS+Clinical+Trials+Group+(AACTG)+&author=MA+Chesney&author=JR+Ickovics&author=DB+Chambers&author=AL+Gifford&author=J+Neidig&author=B+Zwickl&publication_year=2000&hl=en']",10928201,https://doi.org/10.1080/09540120050042891, Chesney 2000 ,additional,CD013080-bbs2-0058,,,10928201,1512.0,,,10928201
CD013080-bib-0059,Department of Health and Human Services - panel on Antiretroviral Guidelines for Adults and Adolescents. ,"Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV, 2017",,,,. hcvguidelines.org/references/dhhs-2017 (accessed prior to 13 June 2019).   ,['citation-other']," Department of Health and Human Services - panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV, 2017. hcvguidelines.org/references/dhhs-2017 (accessed prior to 13 June 2019).    ",[],,, DHHS 2017 ,additional,CD013080-bbs2-0059,,,,,,,
CD013080-bib-0060,European AIDS Clinical Society. ,"European AIDS Clinical Society guidelines. Version 9.0, October 2017",,,,. eacsociety.org/media/guidelines_9.0-english.pdf (accessed prior to 8 July 2018).   ,['citation-other']," European AIDS Clinical Society. European AIDS Clinical Society guidelines. Version 9.0, October 2017. eacsociety.org/media/guidelines_9.0-english.pdf (accessed prior to 8 July 2018).    ",[],,, EACS 2017 ,additional,CD013080-bbs2-0060,,,,,,,
CD013080-bib-0061,"Eshun-Wilson I, Rohwer A, Hendricks L, Oliver S, Garner P. ",Being HIV positive and staying on antiretroviral therapy in Africa: a qualitative systematic review and theoretical model, PLOS One ,2019,14,    ,['citation-journal']," Eshun-Wilson I, Rohwer A, Hendricks L, Oliver S, Garner P. Being HIV positive and staying on antiretroviral therapy in Africa: a qualitative systematic review and theoretical model.  PLOS One 2019;14(1):e0210408. [DOI: 10.1371/journal.pone.0210408] [PMID: 30629648]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1371/journal.pone.0210408', 'https://www.ncbi.nlm.nih.gov/pubmed/30629648', 'https://scholar.google.com/scholar_lookup?title=Being+HIV+positive+and+staying+on+antiretroviral+therapy+in+Africa:+a+qualitative+systematic+review+and+theoretical+model+&author=I+Eshun-Wilson&author=A+Rohwer&author=L+Hendricks&author=S+Oliver&author=P+Garner&publication_year=2019&hl=en']",30629648,https://doi.org/10.1371/journal.pone.0210408, Eshun‐Wilson 2019 ,additional,CD013080-bbs2-0061,,,30629648,94,https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0210408&type=printable,,30629648
CD013080-bib-0062,"Ford N, Nachega JB, Engel M, Mill EJ. ",Directly observed antiretroviral therapy: a systematic review and metaanalysis of randomised clinical trials, Lancet ,2009,374,    ,['citation-journal']," Ford N, Nachega JB, Engel M, Mill EJ. Directly observed antiretroviral therapy: a systematic review and metaanalysis of randomised clinical trials.  Lancet 2009;374(9707):2064-71.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S0140-6736(09)61671-8', 'https://www.ncbi.nlm.nih.gov/pubmed/19954833', 'https://scholar.google.com/scholar_lookup?title=Directly+observed+antiretroviral+therapy:+a+systematic+review+and+metaanalysis+of+randomised+clinical+trials+&author=N+Ford&author=JB+Nachega&author=M+Engel&author=EJ+Mill&publication_year=2009&hl=en']",19954833,https://doi.org/10.1016/S0140-6736(09)61671-8, Ford 2009 ,additional,CD013080-bbs2-0062,,,19954833,111,http://fieldresearch.msf.org/msf/bitstream/10144/88062/1/Ford Lancet DOTS for ARV Review.pdf,,19954833
CD013080-bib-0063,"Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. ",Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy, AIDS ,2002,16,    ,['citation-journal']," Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy.  AIDS 2002;16(13):1835-7.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/00002030-200209060-00021', 'https://www.ncbi.nlm.nih.gov/pubmed/12218400', 'https://scholar.google.com/scholar_lookup?title=Provider+inaccuracy+in+assessing+adherence+and+outcomes+with+newly+initiated+antiretroviral+therapy+&author=R+Gross&author=WB+Bilker&author=HM+Friedman&author=JC+Coyne&author=BL+Strom&publication_year=2002&hl=en']",12218400,https://doi.org/10.1097/00002030-200209060-00021, Gross 2002 ,additional,CD013080-bbs2-0063,12218400,12218400,12218400,89,https://doi.org/10.1097/00002030-200209060-00021,,12218400
CD013080-bib-0064,"Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, et al. ",Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations, Journal of the International AIDS Society ,2017,20,    ,['citation-journal']," Haberer JE, Sabin L, Amico KR, Orrell C, Galárraga O, Tsai AC, et al. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.  Journal of the International AIDS Society 2017;20(1):21371.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7448/IAS.20.1.21371', 'https://www.ncbi.nlm.nih.gov/pubmed/28630651', 'https://scholar.google.com/scholar_lookup?title=Improving+antiretroviral+therapy+adherence+in+resource-limited+settings+at+scale:+a+discussion+of+interventions+and+recommendations+&author=JE+Haberer&author=L+Sabin&author=KR+Amico&author=C+Orrell&author=O+Galárraga&author=AC+Tsai&publication_year=2017&hl=en']",28630651,https://doi.org/10.7448/IAS.20.1.21371, Haberer 2017 ,additional,CD013080-bbs2-0064,,,28364569,58,https://doi.org/10.7448/ias.20.1.21371,,28630651
CD013080-bib-0065,"Horvath T, Azman H, Kennedy GE, Rutherford GW. ",Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection, Cochrane Database of Systematic Reviews ,2012,,    ,['citation-journal']," Horvath T, Azman H, Kennedy GE, Rutherford GW. Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection.  Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No: CD009756. [DOI: 10.1002/14651858.CD009756]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD009756', 'https://scholar.google.com/scholar_lookup?title=Mobile+phone+text+messaging+for+promoting+adherence+to+antiretroviral+therapy+in+patients+with+HIV+infection+&author=T+Horvath&author=H+Azman&author=GE+Kennedy&author=GW+Rutherford&publication_year=2012&hl=en']",,https://doi.org/10.1002/14651858.CD009756, Horvath 2012 ,additional,CD013080-bbs2-0065,22419345,,22419345,481,https://europepmc.org/articles/pmc6486190?pdf=render,,22419345
CD013080-bib-0066,"Kabore L, Muntner P, Chamot E, Zinski A, Burkholder G, Mugavero MJ. ",Self-report measures in the assessment of antiretroviral medication adherence: comparison with medication possession ratio and HIV viral load, Journal of the International Association of Providers of AIDS Care ,2015,14,    ,['citation-journal']," Kabore L, Muntner P, Chamot E, Zinski A, Burkholder G, Mugavero MJ. Self-report measures in the assessment of antiretroviral medication adherence: comparison with medication possession ratio and HIV viral load.  Journal of the International Association of Providers of AIDS Care 2015;14(2):156-62.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1177/2325957414557263', 'https://www.ncbi.nlm.nih.gov/pubmed/25421930', 'https://scholar.google.com/scholar_lookup?title=Self-report+measures+in+the+assessment+of+antiretroviral+medication+adherence:+comparison+with+medication+possession+ratio+and+HIV+viral+load+&author=L+Kabore&author=P+Muntner&author=E+Chamot&author=A+Zinski&author=G+Burkholder&author=MJ+Mugavero&publication_year=2015&hl=en']",25421930,https://doi.org/10.1177/2325957414557263, Kabore 2015 ,additional,CD013080-bbs2-0066,25421930,25421930,25421930,45,https://doi.org/10.1177/2325957414557263,,25421930
CD013080-bib-0067,"Kanters S, Park JJ, Chan K, Socias ME, Ford N, Forrest JI, et al. ",Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis, Lancet HIV ,2017,4,    ,['citation-journal']," Kanters S, Park JJ, Chan K, Socias ME, Ford N, Forrest JI, et al. Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysis.  Lancet HIV 2017;4(1):e31-40.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/S2352-3018(16)30206-5', 'https://www.ncbi.nlm.nih.gov/pubmed/27863996', 'https://scholar.google.com/scholar_lookup?title=Interventions+to+improve+adherence+to+antiretroviral+therapy:+a+systematic+review+and+network+meta-analysis+&author=S+Kanters&author=JJ+Park&author=K+Chan&author=ME+Socias&author=N+Ford&author=JI+Forrest&publication_year=2017&hl=en']",27863996,https://doi.org/10.1016/S2352-3018(16)30206-5, Kanters 2017 ,additional,CD013080-bbs2-0067,,,27863996,233,http://www.thelancet.com/article/S2352301816302065/pdf,,27863996
CD013080-bib-0068,"Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, et al. ",Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study," AIDS (London, England) ",2002,16,    ,['citation-journal']," Knobel H, Alonso J, Casado JL, Collazos J, González J, Ruiz I, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study.  AIDS (London, England) 2002;16(4):605-13.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/00002030-200203080-00012', 'https://www.ncbi.nlm.nih.gov/pubmed/11873004', 'https://scholar.google.com/scholar_lookup?title=Validation+of+a+simplified+medication+adherence+questionnaire+in+a+large+cohort+of+HIV-infected+patients:+the+GEEMA+Study+&author=H+Knobel&author=J+Alonso&author=JL+Casado&author=J+Collazos&author=J+González&author=I+Ruiz&publication_year=2002&hl=en']",11873004,https://doi.org/10.1097/00002030-200203080-00012, Knobel 2002 ,additional,CD013080-bbs2-0068,,,11873004,461,https://doi.org/10.1097/00002030-200203080-00012,,11873004
CD013080-bib-0069,"Kredo T, Adeniyi FB, Bateganya M, Pienaar ED. ",Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Kredo T, Adeniyi FB, Bateganya M, Pienaar ED. Task shifting from doctors to non-doctors for initiation and maintenance of antiretroviral therapy.  Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No: CD007331. [DOI: 10.1002/14651858.CD007331.pub3]    Link to article     Google Scholar     ","['https://doi.org/10.1002/14651858.CD007331.pub3', 'https://scholar.google.com/scholar_lookup?title=Task+shifting+from+doctors+to+non-doctors+for+initiation+and+maintenance+of+antiretroviral+therapy+&author=T+Kredo&author=FB+Adeniyi&author=M+Bateganya&author=ED+Pienaar&publication_year=2014&hl=en']",,https://doi.org/10.1002/14651858.CD007331.pub3, Kredo 2014 ,additional,CD013080-bbs2-0069,24980859,26449702,24980859,55,,,24980859
CD013080-bib-0070,"Lam WY, Fresco P. ",Medication adherence measures: an overview, Biomedical Research International ,2015,2015,    ,['citation-journal']," Lam WY, Fresco P. Medication adherence measures: an overview.  Biomedical Research International 2015;2015:217047.    Link to article     Google Scholar     ","['https://doi.org/10.1155/2015/217047', 'https://scholar.google.com/scholar_lookup?title=Medication+adherence+measures:+an+overview&author=WY+Lam&author=P+Fresco&publication_year=2015&hl=en']",,https://doi.org/10.1155/2015/217047, Lam 2015 ,additional,CD013080-bbs2-0070,26539470,,26539470,1178,https://downloads.hindawi.com/journals/bmri/2015/217047.pdf,,26539470
CD013080-bib-0071,"Lima VD, Bangsberg DR, Harrigan PR, Deeks SG, Yip B, Hogg RS, et al. ",Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level, Journal of Acquired Immune Deficiency Syndromes ,2010,55,    ,['citation-journal']," Lima VD, Bangsberg DR, Harrigan PR, Deeks SG, Yip B, Hogg RS, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.  Journal of Acquired Immune Deficiency Syndromes 2010;55(4):460-5.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1097/QAI.0b013e3181f2ac87', 'https://www.ncbi.nlm.nih.gov/pubmed/20838225', 'https://scholar.google.com/scholar_lookup?title=Risk+of+viral+failure+declines+with+duration+of+suppression+on+highly+active+antiretroviral+therapy+irrespective+of+adherence+level+&author=VD+Lima&author=DR+Bangsberg&author=PR+Harrigan&author=SG+Deeks&author=B+Yip&author=RS+Hogg&publication_year=2010&hl=en']",20838225,https://doi.org/10.1097/QAI.0b013e3181f2ac87, Lima 2010 ,additional,CD013080-bbs2-0071,,20838225,20838225,144,https://doi.org/10.1097/qai.0b013e3181f2ac87,,20838225
CD013080-bib-0072,"Mannheimer SB, Mukherjee R, Hirschhorn LR, Dougherty J, Celano SA, Ciccarone D, et al. ",The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy, AIDS Care ,2006,18,    ,['citation-journal']," Mannheimer SB, Mukherjee R, Hirschhorn LR, Dougherty J, Celano SA, Ciccarone D, et al. The CASE adherence index: a novel method for measuring adherence to antiretroviral therapy.  AIDS Care 2006;18(7):853-61.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1080/09540120500465160', 'https://www.ncbi.nlm.nih.gov/pubmed/16971298', 'https://scholar.google.com/scholar_lookup?title=The+CASE+adherence+index:+a+novel+method+for+measuring+adherence+to+antiretroviral+therapy+&author=SB+Mannheimer&author=R+Mukherjee&author=LR+Hirschhorn&author=J+Dougherty&author=SA+Celano&author=D+Ciccarone&publication_year=2006&hl=en']",16971298,https://doi.org/10.1080/09540120500465160, Mannheimer 2006 ,additional,CD013080-bbs2-0072,,,16971298,170,https://europepmc.org/articles/pmc2567829?pdf=render,,16971298
CD013080-bib-0073,"Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. ",Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLOS Medicine ,2009,6,    ,['citation-journal']," Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.  PLOS Medicine 2009;6(7):e1000097. [DOI: 10.1371/journal.pmed1000097]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1371/journal.pmed.1000097', 'https://www.ncbi.nlm.nih.gov/pubmed/19621072', 'https://scholar.google.com/scholar_lookup?title=Preferred+reporting+items+for+systematic+reviews+and+meta-analyses:+the+PRISMA+statement&author=D+Moher&author=A+Liberati&author=J+Tetzlaff&author=DG+Altman&publication_year=2009&hl=en']",19621072,https://doi.org/10.1371/journal.pmed.1000097, Moher 2009 ,additional,CD013080-bbs2-0073,25555855,,19621072,10283,https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1000097&type=printable,,19621072
CD013080-bib-0074,"Nguyen TM, La Caze A, Cottrell N. ",What are validated self-report adherence scales really measuring?: a systematic review, British Journal of Clinical Pharmacology ,2014,77,    ,['citation-journal']," Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review.  British Journal of Clinical Pharmacology 2014;77(3):427-45.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/bcp.12194', 'https://www.ncbi.nlm.nih.gov/pubmed/23803249', 'https://scholar.google.com/scholar_lookup?title=What+are+validated+self-report+adherence+scales+really+measuring?:+a+systematic+review&author=TM+Nguyen&author=A+LaCaze&author=N+Cottrell&publication_year=2014&hl=en']",23803249,https://doi.org/10.1111/bcp.12194, Nguyen 2014 ,additional,CD013080-bbs2-0074,23803249,,23803249,386,https://europepmc.org/articles/pmc3952718?pdf=render,,23803249
CD013080-bib-0075,"Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. ",Interventions for enhancing medication adherence, Cochrane Database of Systematic Reviews ,2014,,    ,['citation-journal']," Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence.  Cochrane Database of Systematic Reviews 2014, Issue 11. Art. No: CD000011. [DOI: 10.1002/14651858.CD000011.pub4]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD000011.pub4', 'https://www.ncbi.nlm.nih.gov/pubmed/25412402', 'https://scholar.google.com/scholar_lookup?title=Interventions+for+enhancing+medication+adherence&author=R+Nieuwlaat&author=N+Wilczynski&author=T+Navarro&author=N+Hobson&author=R+Jeffery&author=A+Keepanasseril&publication_year=2014&hl=en']",25412402,https://doi.org/10.1002/14651858.CD000011.pub4, Nieuwlaat 2014 ,additional,CD013080-bbs2-0075,,,25412402,2661,https://europepmc.org/articles/pmc7263418?pdf=render,,25412402
CD013080-bib-0076,"Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, et al. ",Adherence to highly active antiretroviral therapy (HAART): a meta-analysis, AIDS and Behavior ,2011,15,    ,['citation-journal']," Ortego C, Huedo-Medina TB, Llorca J, Sevilla L, Santos P, Rodríguez E, et al. Adherence to highly active antiretroviral therapy (HAART): a meta-analysis.  AIDS and Behavior 2011;15(7):1381-96.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s10461-011-9942-x', 'https://www.ncbi.nlm.nih.gov/pubmed/21468660', 'https://scholar.google.com/scholar_lookup?title=Adherence+to+highly+active+antiretroviral+therapy+(HAART):+a+meta-analysis&author=C+Ortego&author=TB+Huedo-Medina&author=J+Llorca&author=L+Sevilla&author=P+Santos&author=E+Rodríguez&publication_year=2011&hl=en']",21468660,https://doi.org/10.1007/s10461-011-9942-x, Ortego 2011 ,additional,CD013080-bbs2-0076,,,21468660,112,,,21468660
CD013080-bib-0077,"Osterberg L, Blaschke T. ",Adherence to medication, New England Journal of Medicine ,2005,353,    ,['citation-journal']," Osterberg L, Blaschke T. Adherence to medication.  New England Journal of Medicine 2005;353(5):487-97.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1056/NEJMra050100', 'https://www.ncbi.nlm.nih.gov/pubmed/16079372', 'https://scholar.google.com/scholar_lookup?title=Adherence+to+medication&author=L+Osterberg&author=T+Blaschke&publication_year=2005&hl=en']",16079372,https://doi.org/10.1056/NEJMra050100, Osterberg 2005 ,additional,CD013080-bbs2-0077,21942628,,16079372,4205,,,16079372
CD013080-bib-0078,"Oxman AD, Lavis JN, Lewin S, Fretheim A. ",SUPPORT Tools for evidence-informed health Policymaking (STP) 10: taking equity into consideration when assessing the findings of a systematic review, Health Research Policy and Systems ,2009,7,    ,['citation-journal']," Oxman AD, Lavis JN, Lewin S, Fretheim A. SUPPORT Tools for evidence-informed health Policymaking (STP) 10: taking equity into consideration when assessing the findings of a systematic review.  Health Research Policy and Systems 2009;7(Suppl 1):S10.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1186/1478-4505-7-S1-S10', 'https://www.ncbi.nlm.nih.gov/pubmed/20018100', 'https://scholar.google.com/scholar_lookup?title=SUPPORT+Tools+for+evidence-informed+health+Policymaking+(STP)+10:+taking+equity+into+consideration+when+assessing+the+findings+of+a+systematic+review+&author=AD+Oxman&author=JN+Lavis&author=S+Lewin&author=A+Fretheim&publication_year=2009&hl=en']",20018100,https://doi.org/10.1186/1478-4505-7-S1-S10, Oxman 2009 ,additional,CD013080-bbs2-0078,20018100,20018100,20018100,3,https://health-policy-systems.biomedcentral.com/track/pdf/10.1186/1478-4505-7-S1-S10,,20018100
CD013080-bib-0079,"Parienti JJ, Verdon R, Bazin C, Bouvet E, Massari V, Larouzé B. ",The pills identification test: a tool to assess adherence to antiretroviral therapy, JAMA ,2001,285,    ,['citation-journal']," Parienti JJ, Verdon R, Bazin C, Bouvet E, Massari V, Larouzé B. The pills identification test: a tool to assess adherence to antiretroviral therapy.  JAMA 2001;285(4):412.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1001/jama.285.4.412', 'https://www.ncbi.nlm.nih.gov/pubmed/11242424', 'https://scholar.google.com/scholar_lookup?title=The+pills+identification+test:+a+tool+to+assess+adherence+to+antiretroviral+therapy&author=JJ+Parienti&author=R+Verdon&author=C+Bazin&author=E+Bouvet&author=V+Massari&author=B+Larouzé&publication_year=2001&hl=en']",11242424,https://doi.org/10.1001/jama.285.4.412, Parienti 2001 ,additional,CD013080-bbs2-0079,,,11242424,6,,,11242424
CD013080-bib-0080,"Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. ",Adherence to protease inhibitor therapy and outcomes in patients with HIV infection, Annals of Internal Medicine ,2000,133,    ,['citation-journal']," Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.  Annals of Internal Medicine 2000;133(1):21-30.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/0003-4819-133-1-200007040-00004', 'https://www.ncbi.nlm.nih.gov/pubmed/10877736', 'https://scholar.google.com/scholar_lookup?title=Adherence+to+protease+inhibitor+therapy+and+outcomes+in+patients+with+HIV+infection&author=DL+Paterson&author=S+Swindells&author=J+Mohr&author=M+Brester&author=EN+Vergis&author=C+Squier&publication_year=2000&hl=en']",10877736,https://doi.org/10.7326/0003-4819-133-1-200007040-00004, Paterson 2000 ,additional,CD013080-bbs2-0080,,,10877736,3578,,,10877736
CD013080-bib-0081,,Review Manager 5 (RevMan 5),,2014,,.   ,['citation-other']," Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014.    ",[],,, Review Manager 2014 [Computer program] ,additional,CD013080-bbs2-0081,41699371,,,,,,41699371
CD013080-bib-0082,"Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, et al. ",Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS, Cochrane Database of Systematic Reviews ,2006,,    ,['citation-journal']," Rueda S, Park-Wyllie LY, Bayoumi AM, Tynan AM, Antoniou TA, Rourke SB, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS.  Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No: CD001442. [DOI: 10.1002/14651858.CD001442.pub2]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD001442.pub2', 'https://www.ncbi.nlm.nih.gov/pubmed/16855968', 'https://scholar.google.com/scholar_lookup?title=Patient+support+and+education+for+promoting+adherence+to+highly+active+antiretroviral+therapy+for+HIV/AIDS+&author=S+Rueda&author=LY+Park-Wyllie&author=AM+Bayoumi&author=AM+Tynan&author=TA+Antoniou&author=SB+Rourke&publication_year=2006&hl=en']",16855968,https://doi.org/10.1002/14651858.CD001442.pub2, Rueda 2006 ,additional,CD013080-bbs2-0082,,,10908497,328,https://europepmc.org/articles/pmc7045748?pdf=render,,16855968
CD013080-bib-0083,"Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. ",Grading quality of evidence and strength of recommendations for diagnostic tests and strategies, BMJ ,2008,336,    ,['citation-journal']," Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.  BMJ 2008;336(7653):1106-10.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.39500.677199.AE', 'https://www.ncbi.nlm.nih.gov/pubmed/18483053', 'https://scholar.google.com/scholar_lookup?title=Grading+quality+of+evidence+and+strength+of+recommendations+for+diagnostic+tests+and+strategies+&author=HJ+Schünemann&author=AD+Oxman&author=J+Brozek&author=P+Glasziou&author=R+Jaeschke&author=GE+Vist&publication_year=2008&hl=en']",18483053,https://doi.org/10.1136/bmj.39500.677199.AE, Schünemann 2008 ,additional,CD013080-bbs2-0083,,,18483053,250,https://europepmc.org/articles/pmc2386626?pdf=render,,18483053
CD013080-bib-0084,"Schünemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. ","GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy", Journal of Clinical Epidemiology ,2020,122,    ,['citation-journal']," Schünemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy.  Journal of Clinical Epidemiology 2020;122:129-41.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2019.12.020', 'https://www.ncbi.nlm.nih.gov/pubmed/32060007', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+21+part+1.+Study+design,+risk+of+bias,+and+indirectness+in+rating+the+certainty+across+a+body+of+evidence+for+test+accuracy+&author=HJ+Schünemann&author=RA+Mustafa&author=J+Brozek&author=KR+Steingart&author=M+Leeflang&author=MH+Murad&publication_year=2020&hl=en']",32060007,https://doi.org/10.1016/j.jclinepi.2019.12.020, Schünemann 2020a ,additional,CD013080-bbs2-0084,,32060007,32060007,257,https://boris.unibe.ch/140680/7/Sch%C3%BCnemann%20JClinEpidemiol%202020_part1_AAM.pdf,,32060007
CD013080-bib-0085,"Schünemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. ","GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables", Journal of Clinical Epidemiology ,2020,122,    ,['citation-journal']," Schünemann HJ, Mustafa RA, Brozek J, Steingart KR, Leeflang M, Murad MH, et al. GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables.  Journal of Clinical Epidemiology 2020;122:142-52.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1016/j.jclinepi.2019.12.021', 'https://www.ncbi.nlm.nih.gov/pubmed/32058069', 'https://scholar.google.com/scholar_lookup?title=GRADE+guidelines:+21+part+2.+Test+accuracy:+inconsistency,+imprecision,+publication+bias,+and+other+domains+for+rating+the+certainty+of+evidence+and+presenting+it+in+evidence+profiles+and+summary+of+findings+tables+&author=HJ+Schünemann&author=RA+Mustafa&author=J+Brozek&author=KR+Steingart&author=M+Leeflang&author=MH+Murad&publication_year=2020&hl=en']",32058069,https://doi.org/10.1016/j.jclinepi.2019.12.021, Schünemann 2020b ,additional,CD013080-bbs2-0085,,32058069,32058069,235,https://boris.unibe.ch/140684/1/Sch%C3%BCnemann%20JClinEpidemiol%202020_part2_AAM.pdf,,32058069
CD013080-bib-0086,"Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP. ",Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART), AIDS and Behavior ,2015,19,    ,['citation-journal']," Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP. Level of adherence and HIV RNA suppression in the current era of highly active antiretroviral therapy (HAART).  AIDS and Behavior 2015;19(4):601-11.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s10461-014-0927-4', 'https://www.ncbi.nlm.nih.gov/pubmed/25342151', 'https://scholar.google.com/scholar_lookup?title=Level+of+adherence+and+HIV+RNA+suppression+in+the+current+era+of+highly+active+antiretroviral+therapy+(HAART)+&author=S+Viswanathan&author=R+Detels&author=SH+Mehta&author=BJ+Macatangay&author=GD+Kirk&author=LP+Jacobson&publication_year=2015&hl=en']",25342151,https://doi.org/10.1007/s10461-014-0927-4, Shilpa 2015 ,additional,CD013080-bbs2-0086,25342151,,25342151,136,https://europepmc.org/articles/pmc4393774?pdf=render,,25342151
CD013080-bib-0087,"Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. ",A meta-analysis of the association between adherence to drug therapy and mortality, BMJ ,2006,333,    ,['citation-journal']," Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality.  BMJ 2006;333(7557):15.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1136/bmj.38875.675486.55', 'https://www.ncbi.nlm.nih.gov/pubmed/16790458', 'https://scholar.google.com/scholar_lookup?title=A+meta-analysis+of+the+association+between+adherence+to+drug+therapy+and+mortality&author=SH+Simpson&author=DT+Eurich&author=SR+Majumdar&author=RS+Padwal&author=RT+Tsuyuki&author=J+Varney&publication_year=2006&hl=en']",16790458,https://doi.org/10.1136/bmj.38875.675486.55, Simpson 2006 ,additional,CD013080-bbs2-0087,,,16790458,1363,https://www.bmj.com/content/bmj/333/7557/15.full.pdf,,16790458
CD013080-bib-0088,"Spinelli MA, Haberer JE, Chai PR, Castillo-Mancilla J, Anderson PL, Gandhi M. ",Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions, Current HIV/AIDS Reports ,2020,17,    ,['citation-journal']," Spinelli MA, Haberer JE, Chai PR, Castillo-Mancilla J, Anderson PL, Gandhi M. Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions.  Current HIV/AIDS Reports 2020;17(4):301-14. [DOI: 10.1007/s11904-020-00502-5]    Link to article     Google Scholar     ","['https://doi.org/10.1007/s11904-020-00502-5', 'https://scholar.google.com/scholar_lookup?title=Approaches+to+objectively+measure+antiretroviral+medication+adherence+and+drive+adherence+interventions+&author=MA+Spinelli&author=JE+Haberer&author=PR+Chai&author=J+Castillo-Mancilla&author=PL+Anderson&author=M+Gandhi&publication_year=2020&hl=en']",,https://doi.org/10.1007/s11904-020-00502-5, Spinelli 2020 ,additional,CD013080-bbs2-0088,32424549,,32424549,116,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7363551,,32424549
CD013080-bib-0089,"Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. ",Self-report measures of medication adherence behavior: recommendations on optimal use, Translational Behavioral Medicine ,2015,5,    ,['citation-journal']," Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use.  Translational Behavioral Medicine 2015;5(4):470-82.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s13142-015-0315-2', 'https://www.ncbi.nlm.nih.gov/pubmed/26622919', 'https://scholar.google.com/scholar_lookup?title=Self-report+measures+of+medication+adherence+behavior:+recommendations+on+optimal+use+&author=MJ+Stirratt&author=J+Dunbar-Jacob&author=HM+Crane&author=JM+Simoni&author=S+Czajkowski&author=ME+Hilliard&publication_year=2015&hl=en']",26622919,https://doi.org/10.1007/s13142-015-0315-2, Stirratt 2015 ,additional,CD013080-bbs2-0089,,,26622919,709,https://europepmc.org/articles/pmc4656225?pdf=render,,26622919
CD013080-bib-0090,UNAIDS. ,"90-90-90: an ambitious treatment target to help end the AIDS epidemic, 2014",,,,. www.unaids.org/en/resources/documents/2017/90-90-90 (accessed 26 March 2018).   ,['citation-other']," UNAIDS. 90-90-90: an ambitious treatment target to help end the AIDS epidemic, 2014. www.unaids.org/en/resources/documents/2017/90-90-90 (accessed 26 March 2018).    ",[],,, UNAIDS 2014 ,additional,CD013080-bbs2-0090,,,,,,,
CD013080-bib-0091,"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. ",A new taxonomy for describing and defining adherence to medications, British Journal of Clinical Pharmacology ,2012,73,    ,['citation-journal']," Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications.  British Journal of Clinical Pharmacology 2012;73(5):691-705.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1111/j.1365-2125.2012.04167.x', 'https://www.ncbi.nlm.nih.gov/pubmed/22486599', 'https://scholar.google.com/scholar_lookup?title=A+new+taxonomy+for+describing+and+defining+adherence+to+medications&author=B+Vrijens&author=S+DeGeest&author=DA+Hughes&author=K+Przemyslaw&author=J+Demonceau&author=T+Ruppar&publication_year=2012&hl=en']",22486599,https://doi.org/10.1111/j.1365-2125.2012.04167.x, Vrijens 2012 ,additional,CD013080-bbs2-0091,,,22486599,1858,https://orbi.uliege.be/bitstream/2268/305261/1/Vrijens__2012_GDO_BJCP.pdf,,22486599
CD013080-bib-0092,"Welch VA, Petkovic J, Jull J, Hartling L, Klassen T, Kristjansson E, et al. ","Chapter 16: Equity and specific populations. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022",,,,. Available from www.training.cochrane.org/handbook.   ,['citation-other']," Welch VA, Petkovic J, Jull J, Hartling L, Klassen T, Kristjansson E, et al. Chapter 16: Equity and specific populations. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.    ",[],,, Welch 2022 ,additional,CD013080-bbs2-0092,,,,,,,
CD013080-bib-0093,"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al, QUADAS-2 Group. ",QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies, Annals of Internal Medicine ,2011,155,    ,['citation-journal']," Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al, QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.  Annals of Internal Medicine 2011;155(8):529-36.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.7326/0003-4819-155-8-201110180-00009', 'https://www.ncbi.nlm.nih.gov/pubmed/22007046', 'https://scholar.google.com/scholar_lookup?title=QUADAS-2:+a+revised+tool+for+the+quality+assessment+of+diagnostic+accuracy+studies&author=PF+Whiting&author=AW+Rutjes&author=ME+Westwood&author=S+Mallett&author=JJ+Deeks&author=JB+Reitsma&publication_year=2011&hl=en']",22007046,https://doi.org/10.7326/0003-4819-155-8-201110180-00009, Whiting 2011 ,additional,CD013080-bbs2-0093,,,22007046,2709,https://doi.org/10.7326/0003-4819-155-8-201110180-00009,,22007046
CD013080-bib-0094,World Health Organization. ,Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003 revision,,,,. ncbi.nlm.nih.gov/books/NBK215589/ (accessed 10 July 2018).   ,['citation-other'], World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003 revision. ncbi.nlm.nih.gov/books/NBK215589/ (accessed 10 July 2018).    ,[],,, WHO 2003 ,additional,CD013080-bbs2-0094,23188179,,,,,,23188179
CD013080-bib-0095,World Health Organization. ,"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV, 2016. Recommendations for a public health approach - second edition",,,,. www.who.int/hiv/pub/arv/arv-2016/en/ (accessed prior to 8 July 2018).   ,['citation-other']," World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV, 2016. Recommendations for a public health approach - second edition. www.who.int/hiv/pub/arv/arv-2016/en/ (accessed prior to 8 July 2018).    ",[],,, WHO 2016 ,additional,CD013080-bbs2-0095,,,,,,,
CD013080-bib-0096,World Health Organization. ,"Consolidated guidelines on person-centred HIV patient monitoring and case surveillance, 2017",,,,. apps.who.int/iris/handle/10665/255702 (accessed prior to 8 July 2018).   ,['citation-other']," World Health Organization. Consolidated guidelines on person-centred HIV patient monitoring and case surveillance, 2017. apps.who.int/iris/handle/10665/255702 (accessed prior to 8 July 2018).    ",[],,, WHO 2017 ,additional,CD013080-bbs2-0096,,,,,,,
CD013080-bib-0097,"Williams AB, Amico KR, Bova C, Womack JA. ",A proposal for quality standards for measuring medication adherence in research, AIDS and Behavior ,2013,17,    ,['citation-journal']," Williams AB, Amico KR, Bova C, Womack JA. A proposal for quality standards for measuring medication adherence in research.  AIDS and Behavior 2013;17(1):284-97.    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1007/s10461-012-0172-7', 'https://www.ncbi.nlm.nih.gov/pubmed/22407465', 'https://scholar.google.com/scholar_lookup?title=A+proposal+for+quality+standards+for+measuring+medication+adherence+in+research&author=AB+Williams&author=KR+Amico&author=C+Bova&author=JA+Womack&publication_year=2013&hl=en']",22407465,https://doi.org/10.1007/s10461-012-0172-7, Williams 2013 ,additional,CD013080-bbs2-0097,22407465,,22407465,196,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3434290,,22407465
CD013080-bib-0098,World Bank. ,"World Bank country and lending groups, 2018",,,,. datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed prior to 8 July 2018).   ,['citation-other']," World Bank. World Bank country and lending groups, 2018. datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed prior to 8 July 2018).    ",[],,, World Bank 2018 ,additional,CD013080-bbs2-0098,30021654,,,,,,30021654
CD013080-bib-0099,"Hine P, Smith R, Eshun-Wilson I, Orrell C, Cohen K, Leeflang MMG, et al. ",Measures of antiretroviral adherence for detecting viral non-suppression in people living with HIV, Cochrane Database of Systematic Reviews ,2018,,    ,['citation-journal']," Hine P, Smith R, Eshun-Wilson I, Orrell C, Cohen K, Leeflang MMG, et al. Measures of antiretroviral adherence for detecting viral non-suppression in people living with HIV.  Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No: CD013080. [DOI: 10.1002/14651858.CD013080]    Link to article     PubMed     Google Scholar     ","['https://doi.org/10.1002/14651858.CD013080', 'https://www.ncbi.nlm.nih.gov/pubmed/30246875', 'https://scholar.google.com/scholar_lookup?title=Measures+of+antiretroviral+adherence+for+detecting+viral+non-suppression+in+people+living+with+HIV+&author=P+Hine&author=R+Smith&author=I+Eshun-Wilson&author=C+Orrell&author=K+Cohen&author=MMG+Leeflang&publication_year=2018&hl=en']",30246875,https://doi.org/10.1002/14651858.CD013080, Hine 2018 ,other_versions,CD013080-bbs2-0099,,,,12,https://archive.lstmed.ac.uk/9027/1/Hine_et_al-2018-Cochrane_Database_of_Systematic_Reviews.pdf,,30246875
